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Abstract 
Many Gram-negative pathogens possess type III secretion systems as part of their 
required virulence factor repertoire. The type III secretion apparatus (TTSA) spans the 
bacterial inner and outer membranes and resembles a syringe and a needle. It is used to inject 
proteins into a host cell's membrane and cytoplasm to subvert normal cellular processes. The 
external portion of the TTSA is a needle that is composed of a single type of protein that is 
polymerized in a helical fashion to form an elongated tube with a central channel that is 2–3 
nm in diameter. We report the first structure of a TTSA needle protein called BsaL from 
Burkholderia pseudomallei determined by nuclear magnetic resonance (NMR) spectroscopy. 
The central part of the protein assumes a helix-turn-helix core domain with two well-defined 
α-helices that are joined by a four-residue linker. Residues that flank this presumably exposed 
core region are not completely disordered, but adopt a partial helical conformation. The 
atomic structure of BsaL and its sequence homology with other TTSA needle proteins suggest 
potentially unique structural dynamics that could be linked with a universal mechanism for 
control of type III secretion in diverse Gram-negative bacterial pathogens. 
The pathogenesis of Shigella flexneri requires a functional TTSA to inject host-altering 
effector proteins directly into the targeted cell. The TTSA exposed needle is an extended 
polymer of MxiH. Invasion plasmid antigen D (IpaD) resides at the tip of the needle to control 
Shigella type III secretion. IpaD (36.6 kDa) has a dumbbell shape with two globular domains 
flanking a central coiled-coil that stabilizes the protein. Known structures of IpaD homologs 
(LcrV from Yersinia and BipD from Burkholderia) all have a similar overall shape. We have 
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identified key MxiH residues located in its PSNP loop and the contiguous surface that 
uniquely contribute to the formation of the IpaD-needle interface as determined by NMR 
chemical shift mapping. Mutation of some of these MxiH residues severely affects the stable 
maintenance of IpaD at the Shigella surface and thus compromises the invasive phenotype. 
Other residues could be mutated to give rise to intermediate phenotypes, suggesting they have 
a role in tip complex stabilization while not being essential for tip complex formation. Initial 
in vitro fluorescence polarization (FP) studies confirmed that specific amino acid changes 
adversely affect the MxiH-IpaD interaction. Meanwhile, none of the mutations appeared to 
have a negative effect on the MxiH-MxiH interactions required for efficient needle assembly.  
We recently demonstrated that bile salts stimulate recruitment of the translocator protein 
IpaB to the Shigella surface where it stably resides with IpaD at the TTSA needle tip. This 
process appears to be initiated by a direct interaction between the bile salt and IpaD. FP 
studies showed that the bile salt deoxycholate (DOC) binds to IpaD. NMR spectroscopy 
confirms a DOC-IpaD interaction and suggests that the IpaD conformation changes upon 
DOC binding. We have identified key IpaD residues that appear to contribute to the formation 
of the IpaD-DOC interface. DOC appears to bind at the middle of the IpaD coiled-coil where 
the top of the N-terminal globular domain packs against the coiled-coil. Several IpaD residues 
in the distal globular domain are also perturbed upon the binding of DOC, suggesting an 
overall conformational change, which may lead to the recruitment of translocator protein IpaB 
to the needle tip. Mutation of some of these perturbed residues affects the ability of IpaD to 




 I would like to thank my mentors Dr. William Picking and Dr. Wendy Picking. I 
have been extremely privileged to have two wonderful mentors who have helped me in 
every aspect of my development as a researcher and as a person. I would like to thank 
them for the valuable training that I received in the lab. I am thankful for their 
encouragement for presenting my research at local, regional and national meetings which 
tremendously helped my professional development. I am extremely grateful to Dr. 
William Picking and Dr. Wendy Picking for considering their students all the time and 
providing a fun learning environment for us. 
 I would like to thank Dr. Roberto De Guzman for teaching me everything NMR and 
more. I am blessed to have another advisor helping my professional development. I am 
thankful to him showing me the world of structural biology. I am grateful for his patience 
as well as being a fun PI to work for. I would like to thank Yu Wang in Dr. De Guzman’s 
lab for his help on my NMR experiments. I am grateful for the financial support received 
from the Department of Molecular Biosciences and Division of Biological Sciences. I 
would like to thank my other committee members, Dr. Dr. Krzysztof Kuczera, Dr. Mark 
Richter and outside member Dr. Russ Middaugh, for serving on my doctoral dissertation 
committee. I also thank former committee member Dr. Erik Floor who is now retired. I 
am thankful for all the administrative support provided by John Connolly, et al. 
 I would like to thank our former postdoc fellow Dr. Marianela Espina for showing 
me the ropes when I started in the lab. I would also like to thank former graduate student 
Dr. Roma Kenjale for her help in the lab and teaching microbiology laboratory. I would 
like to thank previous and current undergraduates, Andrew Olive, Nathan Smith and Phil 
Adam who have contributed to this project in numerous ways. I also thank current lab 
members postdoc fellow Dr. Nick Dickenson, graduate student Chelsea Epler and 
undergraduate student Phil Adam. I am extremely grateful for having a group of fun 
people to work with and everyday I look forward to going to work.  
 Last but not least, I thank my parents for constantly encouraging me to pursue my 
dreams. They have been unconditionally supporting my career choices which most of the 
time are challenging and uncertain instead of being safe. It has been a rollercoaster ride 
for them sending their only child far away across the ocean. I am grateful for their love, 
support and encouragement which make me the person I am now. I could not have done 





TABLE OF CONTENTS 
Abstract                                          3   
Acknowledgements                                 5 
List of Tables and Figures                                8 
Chapter 1: Introduction                              11 
Shigella and shigellosis                                                   11 
Discovery of Type III Secretion System a of Shigella                           14 
Overview of type III secretion system                                       15 
Details of the type III secretion system from Gram-negative pathogens             19 
CHAPTER 2: Materials and Methods 
Materials                                                              37 
Buffers and Reagents                                                    38 
Bacterial strains, media and growth conditions                                38 
Cloning of bsaL and bsaL mutants from Burkholderia pseudomallei K96243 for protein 
expression                                                             38 
Purification of Recombinant protein BsaLΔ5                                  39 
Expression of isotopic labeled recombinant BsaLΔ5 in minimal media for NMR 
spectroscopy                                                           39 
NMR spectroscopy and structure determination for BsaL                        40 
Cloning of mxiH and mxiH mutants for protein expression                       41 
Purification of Recombinant protein MxiHΔ5                                 42 
Examining MxiH folding by Circular dichroism spectroscopy                    42 
 6
Expression of isotopic labeled recombinant MxiHΔ5 in minimal media for NMR 
spectroscopy                                                           43 
NMR spectroscopy and backbone assignment of MxiHΔ5                       43 
Purification of recombinant IpaD                                           44 
NMR chemical shift mapping of the interaction between MxiH and IpaD           45 
Cloning of mxiH mutants for expression in S. flexneri mxiH null strain SH116       45 
Preparation of mxiH 5 mutants for expression in E. coli Tuner (DE3)            45 
Cloning of ipaD mutants for expression in S. flexneri ipaD null strain SF622        46 
Cloning of ipaD mutants for protein expression                               46 
Western blot analysis                                                    47 
Assay of overnight Ipa secretion in Shigella mutants                           48 
Assay of Congo red (CR) induction of TTSS secretion in Shigella                 49 
Growth and maintenance of Henle 407 epithelial cells, preparation of cell culture plates 
Assay of bacterial entry into cultured epithelial cells                            49 
Contact-mediated hemolysis of sheep red blood cells                           50 
Purification of long TTSA needle from S. flexneri                              51 
Visualization of purified needles by transmission electron microscopy (TEM)        52 
Fluorescence polarization (FP) spectroscopy for measuring the interaction of IpaD with 
FITC-DOC                                                            52 
Immunofluoresence microscopy for the presence of IpaD at Shigella surface         53 
NMR spectroscopy and backbone assignment of IpaD38-321                                    54 
 7
NMR chemical shift perturbation for the interaction between IpaD and deoxycholate 
(DOC)                                                                55 
CHAPTER 3: Solution Structure of Monomeric BsaL, the Type III Secretion Needle 
Protein of Burkholderia pseudomallei  
Introduction                                                            57 
Result                                                                 61 
Discussion                                                             70 
CHAPTER 4: Identification of the MxiH Needle Protein Residues Responsible for 
Anchoring Invasion Plasmid Antigen D (IpaD) to the Type III Secretion Needle Tip  
Introduction                                                            75 
Result                                                                 77 
Discussion                                                             95 
CHAPTER 5: NMR Analysis of the Influence Deoxycholate (DOC) Binding has on 
the Structure of Invasion Plasmid Antigen D (IpaD) of Shigella flexneri  
Introduction                                                            98 
Result                                                                101 
Discussion                                                            123 
CHAPTER 6: Discussion and Summary                                   126 
Bibliography                                                    136 
Appendix A: Buffers and Reagents                                       150 
Appendix B: Primer Table                                              155 
Appendix C: List of abbreviations used                                   157 
 
 8
LIST OF TABLES AND FIGURES 
Table 1: Structure statistics for the 20 low energy structures of BsaLΔ5             66 
Table 2: List of proteins that are structurally homologous to the core domain of BsaL 73 
Table 3: MxiH mutants used in this study                                     85 
Table 4: Phenotype of MxiH mutants                                        87 
Table 5: Association of MxiH mutants with FM-IpaD by fluorescence polarization    92 
Table 6: IpaD residues showing chemical shift perturbation upon the titration of DOC 118 
Table 7: The effect of selected IpaD mutations on Shigella invasiveness           121 
Figure 1: Shigella invasion of colonic epithelial cells                           13 
Figure 2: Diagram of the S. flexneri Mxi-Spa TTSS                             21 
Figure 3: The TTSS needle proteins of different bacteria show sequence conservation 59 
Figure 4: The 2D 1H–15N HSQC of the recombinant 15N-labeled BsaLΔ5           62 
Figure 5: Secondary chemical shift index                                     64 
Figure 6: NMR structures of BsaLΔ5                                        65 
Figure 7: Interaction of IpaD with MxiH                                     78 
Figure 8: Identify MxiH Residues Interacting with IpaD by NMR Spectroscopy      80 
Figure 9: A. HNCA spectra of MxiH showing as 13C, 1H strips for residues W10-L15 82 
Figure 10: Transmission electron micrographs of sheared needles from S. flexneri SH116 
expressing MxiHL47D (A) or MxiHY50F (B) from a pRK2 plasmid                  91 
Figure 11: Model of MxiH-IpaD binding                                     94 
Figure 12: Fluorescent polarization change of FITC-DOC incubated with IpaD      103 
 9
Figure 13: Computational simulated docking of DOC onto the structure of IpaD     105 
Figure 14: SDS-PAGE of isotopically labeled IpaD38-321                        111 
Figure 15: Overlay of TROSY spectra of specific amino acid labeled IpaD38-321      112 
Figure 16: TROSY spectrum of IpaD38-321 with primary sequence assignment labeled 114 
Figure 17: Chemical shift perturbation of 15N-labeled IpaD38-321                  115 
Figure 18: Titration of 15N-labeled IpaD38-321 with increasing amounts of DOC      117 
Figure 19: IpaD residues that are perturbed by DOC binding are mapped on the surface of 
the crystal structure of IpaD (Protein Data Bank code 2j0o)                     119 
Figure 20: Structures of TTSS needle and tip proteins                          128 






CHAPTER 1: Introduction  
 
1. Shigella and shigellosis 
There are approximately 165 million cases of dysentery worldwide each year that 
result from shigellosis and this leads to more than one million deaths annually (184). 
Shigellosis causes symptoms ranging from mild diarrhea to severe dysentery 
accompanied by fever, stomach cramping, severe abdominal pain and frequent stools with 
blood and mucus (30). The majority of shigellosis cases occur in developing countries 
involving young children due to poor sanitation, especially the lack of clean water (15). In 
addition to that, about 580,000 cases of shigellosis are reported in industrialized countries 
each year, in part due to the emergence of multiple antibiotic resistant strains, and rapid 
international travel coupled with the need to send humanitarian aid personnel to endemic 
areas. While it is often underreported in industrialized regions, shigellosis is not unusual 
in institutional settings like day-cares and nursing homes (125). The Centers for Disease 
Control estimates 440,000 cases of shigellosis in the United States each year, 85% of 
which are caused by S. sonnei (30).  
Shigella is Gram-negative, rod-shaped, nonmotile, facultative anaerobic pathogen 
that only infects primates. There are three major species of Shigella that are responsible 
for shigellosis: S. sonnei, S. flexneri and S. dysenteriae. S. sonnei is the causative agent of 
most shigellosis cases in industrialized countries, where it accounts for 77% of the cases 
comparing to 15% in developing countries. S. flexneri causes 60% of shigellosis cases in 
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developing countries. It is the most frequently isolated Shigella species around the world. 
S. dysenteriae is the causative agent of epidemic dysentery and is responsible for 
outbreaks in confined populations like refugee camps. S. dysenteriae infection causes 
more severe symptoms because of the release of Shiga toxin and it is difficult to treat due 
to its resistance to multiple antibiotics (30). 
Shigellosis is transmitted by the fecal-oral route, usually through contaminated food 
and water. These bacteria can survive the low gastric pH, and thus a very low infectious 
dose of 10-100 bacteria is sufficient to cause disease (60). The disease is usually 
self-limiting in healthy adults; however, it can be fatal in young children under the age of 
five due to dehydration and complications caused by malnutrition in the developing 
world. Once consumed, the bacteria pass through M cells in the large intestine to access 
the basal side of the epithelial lining where they encounter macrophages. The pathogens 
induce apoptosis in the macrophages. They then invade colonic epithelial cells from their 
basal sides and subsequently spread between epithelial cells using actin-based motility to 
avoid encountering the outside environment and the host immune response (see Figure 1) 
(160). Shigella invasiveness is due to virulence factors encoded by a 200-kb high 
molecular weight virulence plasmid, within which a 31-kb conserved region encodes two 
major loci that are required for the invasive phenotype to encode the type III secretion 




Figure 1. Shigella invasion of colonic epithelial cells. Shigella crosses the epithelial cell 
lining through transcytosis by M cells and encounters macrophages, causing apoptosis of 
the macrophages. The released pathogens invade the epithelial cells from their basal sides 
and can spread to adjacent cells without encountering outside environment. 
Proinflammatory signaling activates the innate immune response involving NK cells and 
PMN (polymorphonuclear leukocyte). The PMNs eventually kill the bacteria (160). 
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2. Discovery of type III secretion system (TTSS) of Shigella  
The invasive ability of Shigella is due to several virulence factors encoded by a high 
molecular weight 200-kb virulence plasmid. Two major loci are required for the invasive 
phenotype and they encode a type III secretion system (TTSS). The mxi locus was found 
to be essential for Shigella virulence in 1991, when Maurelli et al. identified the mxiA and 
mxiB loci as essential virulence components on the Shigella virulence plasmid (8). These 
two genes were part of a large operon with additional mxi (major exporter of invasins) 
genes that are required for transport of the Ipa (invasion plasmid antigen) proteins to the 
bacterial surface. When either mxiA or mxiB were inactivated, the resulting strain failed to 
secrete Ipa proteins into the culture medium. In 1992, Venkatesan et al. found that the spa 
locus (surface presentation of antigens) is also required for Shigella invasiveness (180). 
Mutants in this locus also failed to transport Ipa proteins to the bacterial surface. The mxi 
and spa gene loci were later found to cooperatively encode a protein secretion apparatus 
called the type III secretion system (TTSS) (8, 180).  
More than 20 protein products encoded by the mxi and spa loci have been identified 
and found to be essential for type III secretion (TTS) (171). TTSSs have been shown to 
mediate communication between many different bacteria and their eukaryotic host cells 
(96), and they turn out to be a key virulence determinant in the pathogenesis of Shigella. 
More recent findings showed that the TTSS apparatus is a multi-protein assembly that is 
composed of a basal body spanning the bacterial inner and outer membranes, an external 
needle-like structure and, most recently, a tip complex at the top of the needle (16, 63, 
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129). A subset the virulence proteins secreted by the Shigella TTSS are called invasion 
plasmid antigens (Ipa proteins) and at least one of these, IpaD, is secreted to serve as the 
primary needle tip complex protein. Ipa proteins (IpaB and IpaC) are believed to 
accumulate in the bacterial cytoplasm before secretion where they are bound to their 
cognate molecular chaperones (123, 138). These Ipa proteins are subsequently secreted so 
that they can act together to promote uptake of the bacterium by its eukaryotic host cell. It 
was just recently shown that IpaD is at the Shigella TTSA needle tip prior to secretion 
induction (63). IpaD was originally thought to be one of the effectors that trigger uptake 
signals in the host cell, along with IpaB and IpaC. IpaD’s role is now known to be much 
more complicated (details later). The Shigella TTSS is activated by intimate host cell 
contact prior to invasion, however, the mechanism of this induction is not yet well 
understood. The roles of IpaD and the translocator proteins IpaB and IpaC is this process 
remain unknown, but will be touched upon in this manuscript (10, 192). 
 
3. Overview of the type III secretion system (TTSS) 
There are many different ways for bacteria to transfer effector proteins from their 
own cytoplasm to the external environment or into host cells. Prime among these is the 
TTSS which is an essential virulence element used by many Gram-negative plant and 
animal pathogens to manipulate their hosts (96). The TTSS is conserved among many 
Gram-negative bacterial species and functions to transport host-altering bacterial effector 
proteins from the bacterial cytoplasm across the two bacterial membranes, the host cell 
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membrane, and directly into the host cell cytoplasm in a single step (44, 72). TTSSs have 
been identified in diverse groups of pathogens. Important human pathogens are among 
these including enteropathogenic Escherichia coli (EPEC), Salmonella enterica, Yersinia 
spp., Shigella spp., Burkholderia spp., and Pseudomonas aeruginosa. Illnesses caused by 
these pathogens range from opportunistic infections by P. aeruginosa to gastroenteritis 
caused by S. typhimurium, Shigella and Yersinia enterocolitica to overwhelming systemic 
infections by Yersinia pestis, Salmonella typhi and Burkholderia pseudomallei. In all 
cases, the TTSS contributes to infection by allowing the bacteria to communicate with 
eukaryotic cells. The outcome of this interspecies communication varies with pathogen 
and host cell type. TTS has also been implicated in plant diseases caused by 
Gram-negative pathogens, and in flagellar assembly (35, 36, 44, 112).  
The most conserved component of TTSSs is the TTS apparatus (TTSA), which is a 
multi-protein assembly that visually resembles a syringe and needle (16). The TTSA 
consists of more than 20 different component proteins with a complex basal body 
spanning the inner and outer membrane and the external needle exposed on the surface of 
the bacterium (17, 112, 162, 171). While the TTSA is relatively well-conserved among 
related species, it is also highly adapted to individual bacterial virulence mechanisms (72, 
96).  
 TTSAs (also called secretons or injectisomes) have been purified from Shigella, 
Salmonella, and EPEC and visualized by electron microscopy (EM) (17, 112, 162, 171). 
The extracellular structures have also been visualized for the animal pathogen P. 
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aeruginosa (142), the plant pathogen Pseudomonas syringae (91) and the Yersinia spp. 
(129). The EM studies show that TTSAs from a wide range of pathogens share a common 
structure. The basal body structure is very similar to the flagellar basal body, and it is 
connected to an elongated extracellular hollow structure called the “needle” in animal 
pathogens and the “Hrp pilus” in plant pathogens (16). The needle displays a certain 
amount of heterogeneity in its features among the various pathogens having TTSSs. 
While the Hrp pilus of P. syringae is long and flexible, the MxiH and PrgI needles from 
Shigella and Salmonella, respectively, are short and relatively rigid. The EPEC needle has 
an additional filament attached to the needle called the “EspA filament” (112, 162, 171). 
In the flagellar apparatus, the hook is probably the equivalent of the needle (18). Except 
for the flagellar system these diverse TTSAs are believed to have a common function of 
translocating effector proteins into host cells for manipulating host functions (96, 112, 
162, 171).  
 Comparison with bacterial flagella. The Gram-negative bacterial flagellum is 
composed of the non-motor structural elements and the motor elements (116). The 
non-motor basal body is composed of the MS ring, the rod, the L and P rings, the hook 
and associated hook–filament junction zones, and the filament with its distal cap (116). 
The motor consists of structural components embedded in the cell cytoplasmic 
membranes, including an ATPase that is driven by the proton motive force to promote the 
mechanical movement (116). Although there is much debate about the evolution of the 
TTSS, there is clearly an evolutionary relationship between the TTSS and the bacterial 
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flagellar system. In spite of only weak sequence similarities, a number of the components 
of the TTSS appear to be structurally and functionally homologous to those of the 
flagellar system. 
Both TTSS and flagella share the ability to translocate bacterial proteins out of the 
bacterium. There are more than 20 proteins that contribute to form the TTSA and nearly 
all of them are essential for function (96). About 10 cytoplasmic or inner membrane 
proteins show sequence similarity to flagellar hook-basal body (HBB) proteins, while 
some others show no obvious sequence homology but share functional similarity. The 
TTSA and needle visually resemble the HBB with a 2-3nm inner channel that is similar to 
the inner channel of the flagellum (17, 126). External structural components and later 
effectors are translocated through the channel in a partially unfolded state because of the 
relatively small inner diameter. The hydrophobic translocator proteins of the TTSS are 
secreted and inserted into host membrane to open a path for later bacterial effectors to 
pass through into the cytoplasm of eukaryotic host cell. The insertion of a translocon pore 
into the host cell membrane is essential for later translocation of TTSS effectors. During 
assembly of the flagellum, new filament subunits are inserted directly under a cap like 
structure (136). Although there has been no cap identified in any TTSS, it is possible that 
the translocators might be functionally homologous to the flagellar cap FliD and the 
filament protein (FliC or flagellin). FliD allows insertion of flagellin at the flagellar tip 
which may be equivalent to tip complex mediated insertion of translocator proteins into 
the host cell membranes by the TTSS (187). FliD is a pentamer, while the TTSS tip 
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proteins LcrV from Yersinia and IpaD from Shigella were recently suggested to likely 
form a pentamer at the needle tip as well. This leads to the possibility that there is 
structural and functional homology between the tip complex and the flagellar cap (20, 
101). Whether FliD has a TTSS homolog is still a much debated question.   
 
4. Details of the type III secretion system from different Gram-negative 
pathogens  
There are more than 25 different Gram-negative bacteria species utilizing a single or 
multiple TTSSs as key virulence determinants. The TTSS is used to deliver 
host-interfering bacterial effectors into the membrane and cytoplasm of their host cells in 
a single injection step. Quite a few important Gram-negative human pathogens require the 
TTSS for manipulating their host cells. This can lead to invasion of the host cells, killing 
of these targets, or specialized forms of adherence/colonization, depending upon the 
pathogen and its specific TTSS. Below are descriptions of some of these pathogens and 
the unique features of their TTSSs.  
 
4a. Shigella flexneri 
Structure of the Shigella type III secretion appratus (TTSA). The first TTSA 
structure was reported from S. typhimurium in 1998 (112). In 1999, Blocker et al. 
proposed that the TTSA of S. flexneri is composed of a needle, a transmembrane neck and 
a cytoplasmic bulb based on EM visualization (16). In 2000, Tamano et al. isolated and 
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purified the intact TTSA from S. flexneri (171). Purified TTSA complexes were analyzed 
by SDS-PAGE to separate the component proteins (17, 171) and identify them by 
immunoblot analysis. MxiD, MxiG, MxiJ and MxiH were identified as major components 
of the TTSA. MxiH is polymerized to form the external needle and the other proteins are 
proposed to be part of the basal structure (171).  
The basal structure is composed of two rings with 31.6 ± 0.3 nm in length (171). The 
upper ring is 9.5 ± 0.9 nm wide and 15.0 ± 1.3 nm thick, while the lower ring is 26.1 ± 
1.3 nm wide and 11.2 ± 0.2 nm thick (171). Multiple copies of MxiD, MxiG, MxiJ and 
MxiM appear to form the two stacked rings of the basal body (131, 132)(Figure. 2). MxiD 
was proposed to form the upper ring doublet embedded in the bacterial outer membrane 
(17). MxiD was hypothesized to project downward from the outer membrane, traverse the 
peptidoglycan layer and extend to the inner membrane (131, 132). MxiG and MxiJ were 
previously reported as integral inner membrane proteins (6, 7). Thus, Blocker et al. 
proposed that MxiG and MxiJ form rings in the inner membrane. Soon after, MxiM was 
also identified as part of the basal structure (161). MxiM is a lipoprotein that is attached 
to the inner surface of the outer ring doublet via its acyl moiety, where it interacts with 
MxiD in the outer membrane and stabilizes MxiJ in the inner membrane (161). The 
proposed positions of MxiD, MxiG, MxiJ and MxiM are shown in Figure 2. Further 
comparison to the flagellar system led to the identification of flagellar C-rod (cytoplasmic 




Figure 2. Diagram of the S. flexneri Mxi-Spa TTSS. The basal body spans the bacterial 
inner and outer membranes. The hollow needle is exposed with a tip complex formed by 
IpaD at its top. Direct contact with host cell triggers the secretion of the IpaB/C 
translocon (160). (HM: host membrane; LPS: lipopolysaccharide; OM: outer membrane; 
IM: inner membrane)
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on the cytoplasmic side of the basal body structure (17, 18). The components appear to 
have homologs in S. flexneri TTSS spa locus (64, 135). The Spa proteins were proposed 
to be the putative C-rod components in the Shigella TTSA complex based on sequence 
homology even though these proteins could not be identified in the isolated needle 
complexes (17). The putative Shigella C-rod components are cytoplasmic 
membrane-associated proteins that presumably control secretion of other TTSA 
components. Similar homologs were identified in the S. typhimurium SPI1 TTSA (135). 
Recently, it was demonstrated that Spa33 is, in fact, a C-rod component of the Shigella 
TTSA (127). It was shown that Spa33 interacts with MxiG and MxiJ in the basal body, 
and with Spa47 (the ATPase which is homologous to the flagellar ATPase, FliI) which is 
proposed to power type III secretion (18, 127).  
More detailed studies were reported on the extracellular components of TTSA in 
recent years. Cryo-EM results showed that the Shigella needle is a hollow structure with a 
channel having a 2-3nm inner diameter, a 7nm outer diameter, and a length of 50-60nm 
(38). MxiH was identified as a major needle component, whereas MxiI was termed as a 
minor needle component since deletion of either of the proteins resulted in needleless 
TTSAs. Later, it was suggested that MxiI forms the periplasmic rod structure to which the 
MxiH needle is attached, however, whether the rod structure exists is still a debated 
question since so far there is no conclusive visualization of the rod (18, 172). MxiH is 
polymerized in a helical fashion with 5.6 subunits per turn and a 24 Å pitch (38). Later 
research on the MxiH monomeric structure and cryo-EM needle imaging suggests that the 
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major axis of MxiH monomers lines up with the major axis of the needle, while the head 
domain of the protein is surface exposed and the N-terminal and C-terminal tails are 
likely inside with the C terminus buried in the wall (55).   
  Invasion plasmid antigen (Ipa) proteins. Five antigenic Shigella proteins were 
consistently observed through immunoblot analysis using convalescent serum from 
recovered shigellosis patients (86, 106, 121, 133, 158). The largest protein was identified 
as IcsA and was encoded on the virulence plasmid outside the 37-kb locus that is essential 
for Shigella invasion. The other four proteins were indeed encoded within the invasion 
locus and were originally called a (78 kDa), b (62 kDa), c (43 kDa) and d (38 kDa). The 
locus was identified as the ipa locus by Buysse et al. when they named the genes invasion 
plasmid antigens (ipa) A-D in the order of molecular mass for the encoded proteins (25). 
IpaA-D were encoded in a single operon, the ipaBCDA operon (12). 
Inactivation of ipaB, C or D resulted in a negative Serény test, abolished contact 
hemolysis, and eliminated invasion of epithelial cells. Complementation with a wild-type 
copy of the genes restored virulence capacity. IpaB, C and D were thus identified as the 
main effectors for Shigella invasion (124). Deletion of ipaA did not affect the invasive 
ability of S. flexneri (13, 124), although later studies showed that ipaA-null mutant is 
unable to induce rearrangements of host cytoskeleton following invasion, which 
compromises bacterial cell to cell spread (175). It was reported that IpaA binds viniculin, 
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and may be involved in the efficient resolution of filopodia and lamellopodia following 
uptake of the bacteria by epithelial cells.  
 IpaB plays a critical role in cellular invasion (32). Together with IpaC, it forms a 
translocon pore in the host membrane, which is the first step for injecting later bacterial 
effectors into host cytoplasm. IpaB, along with IpaC, has also been implicated in lysis of 
the phagocytic vacuole following cellular uptake (11, 94). It was also demonstrated that 
IpaB, in conjunction with IpaD, is involved in the proper control of type III secretion 
(122). Deletion of either ipaB or ipaD results in massive, uncontrolled secretion of the 
remaining Ipa proteins. Although IpaD is the only Ipa protein initially found present on 
the Shigella surface, addition of the bile salt deoxycolate (DOC) can induce the stable 
colocalization of IpaB on the Shigella surface with IpaD. This may represent the first step 
of T3SS induction (63, 137). IpaB and IpaD together appear to regulate secretion from the 
Shigella surface prior to receiving a secretion signal triggering later effector secretion. 
  IpaB and IpaC are hydrophobic proteins that are predicted to contain 
transmembrane helices that allow them to insert into target cell membranes (83, 113). 
They exist in the bacterial cytoplasm independently bound to the chaperone protein IpgC 
prior to their secretion (123). Upon receiving the host cell contact signal, secretion is 
activated, causing the release of IpaB and IpaC from IpgC, which allows them to enter 
and exit the Shigella TTSA. Following their secretion, IpaB and IpaC combine to form a 
pore complex within the host cell cytoplasmic membrane (123, 138). 
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 In addition to controlling secretion, IpaD has been shown to aid the insertion of the 
translocon pore into eukaryotic membranes (146). Formation of the IpaB-C pore thus 
represents final assembly of a molecular conduit with IpaD and the B-C complex linking 
the bacterial cytoplasm to the epithelial cell cytoplasm. The full conduit is composed of 
the TTSS basal body which spans bacterial inner and outer membranes, the external 
needle, the tip complex IpaD and the IpaB-C pore complex that spans the host membrane. 
This allows direct translocation of later effector proteins from the bacterial cytoplasm into 
the host cell cytoplasm. IpaA is among the 20 or so proteins translocated into the host 
cytoplasm (156, 176). Since IpaB, C and D are necessary for translocation of proteins into 
the host cell, they have been termed the “translocators”, while the proteins that are 
injected into host cell cytoplasm to alter host cell function are termed “effectors” of 
invasion (3, 4). It cannot be ruled out that IpaB, C and D also have effector functions 
since IpaB is known to trigger apoptosis in macrophages by activating caspase 1 and IpaC 
is directly involved in mediating entry into epithelial cells (173, 193). 
 
4b. TTSS in other Gram-negative bacteria – comparison with the S. flexneri 
TTSS  
Salmonella typhimurium Salmonella spp. cause a variety of diseases ranging from 
gastroenteritis to bacteremia and enteric fever (96). Some Salmonella are limited to a 
particular host like S. typhi which only cause systemic typhoid fever in humans. Others, 
like S. typhimurium and S. enteritidis, have a broader host range causing a variety of 
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diseases, depending on the host (140). Salmonella gastroenteritis occurs through 
contaminated food and water (78, 79). In contrast with Shigella, Salmonella is not as 
stable when exposed to the low gastric pH. As a result, a much higher infectious dose of 
≥104 organisms is required for human infection (29, 60). Salmonella has long been a 
model system for studying bacterial invasion of epithelial cells.  
Salmonella species contain two TTSSs encoded by two different chromosomal loci, 
termed SPI-1 and SPI-2 (Salmonella Pathogenecity Islands) (70). These two TTSSs play 
very different roles in pathogenesis of Salmonella. The TTSS encoded by SPI-1 is similar 
to the Shigella TTSS and the Burkholderia pseudomallei Bsa TTSS, which is required for 
the initial invasion of intestinal mucosal cells, whereas the one encoded by SPI-2 is 
required for survival in macrophages and in the establishment of systemic infection (70, 
96). 
 After ingestion, Salmonella reaches the intestine where they invade the intestinal 
epithelia after transcytosis across M-cells (33). There is also evidence that Salmonella can 
invade the epithelial cells surrounding the M-cells directly from the apical surface (45, 
170). Shigella, on the other hand, invades only via the basal surface. After crossing the 
M-cell, Salmonella is taken up by underlying macrophages (45). Once in the 
macrophages, the bacteria can either multiply within the resulting phagosomal vacuole or 
can induce macrophage apoptosis, which allows bacterial release at the basal surface of 
the mucosal epithelium. Survival within the macrophages is mediated by the TTSS 
encoded by SPI-2 while macrophage apoptosis is mediated by SPI-1 TTSS (45, 96). The 
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invasion of the epithelial cell at their basal surface is also mediated by the TTSS encoded 
by SPI-1 (96, 168). As with Shigella, Salmonella invasion of host cells is accompanied by 
membrane ruffling at the site of host cell contact caused by major rearrangement of the 
actin cytoskeleton (66).  
The structure of the Salmonella SP-I TTSS needle component PrgI was solved in 
2007 (182). PrgI from Salmonella, MxiH from Shigella and BsaL from Burkholderia all 
have a similar overall two helix bundle architecture with a tight Pro-X-X-Pro linker/turn 
(55, 191), suggesting a helical packing for the Salmonella needle that is similar to that of 
the previously described Shigella needle. The initial protein secreted by Salmonella SPI-1 
TTSS are called Sips (Salmonella invasion proteins), which are homologous to the 
Shigella Ipa proteins and B. pseudomallei Bip proteins. SipD and IpaD have significant 
amino acid sequence similarity especially at their C-termini which is believed to be 
essential for anchoring these proteins at the needle tip. SipB, SipC and SipD are required 
for invasion like their Shigella homologs IpaB, IpaC and IpaD, while SipA is expendable 
for this process (104, 105). After host cell contact, SipB and SipC are secreted through 
the Salmonella TTSA and inserted into the target membrane to form the translocon pore 
(45, 71). Mutations in sipB, sipC and sipD individually prevent the translocation of SipB 
and SipC into the host cell, indicating that all three proteins are required for translocon 
formation (45), as is the case for their counterparts in Shigella. 
 Burkholderia pseudomallei B. pseudomallei is the causative agent of mellioidosis, 
an illness that can manifest itself in humans as an acute, sub-acute or chronic infection 
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(52). Melioidosis can be an acute lung infection, systemic blood stream infection or 
chronic suppurative abscesses (28). Infection by this saprophytic bacterium is endemic to 
southeastern Asia and northern Australia, and has the potential for global spread (52). 
Acute mellioidosis is a potentially fatal septicemic infection, while the sub-acute form of 
the disease can lead to the formation of systemic abscesses in multiple organ systems 
(49). Asymptomatic infections can progress to clinical mellioidosis as is often observed in 
endemic regions (51). Acute and sub-acute mellioidosis can also give rise to B. 
pseudomallei latency and the potential for delayed, and often fatal, relapse despite 
appropriate antibiotic therapy during the initial infection (31, 49). B. pseudomallei are 
found in contaminated water and soil, from which humans and animals eventually 
become infected through direct contact with the organism (27). Humans can also be 
infected through inhalation of dust containing the organism. Person-to-person 
transmission has also been reported (28). B. pseudomallei and its close relative 
Burkholderia mallei (causative agent of glanders) are considered important bioterrorism 
agents due to their ready world-wide availability and their ability to be transmitted by 
aerosol (167). No vaccine is currently available against this organism.  
Several virulence factors have been implicated in the pathogenesis of B. 
pseudomallei, including a polysaccharide capsule, secreted hemolysins, lipases, proteases 
and siderophores (153). It was reported that B. pseudomallei has at least 3 different loci 
that encode putative TTSSs (152). One of the loci, the bsa (Burkholderia secretion 
apparatus), is encoded within a recently identified pathogenicity island that is similar to 
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those encoded by the Shigella virulence plasmid (the Mxi/Spa TTSS) and the Salmonella 
pathogenicity island SPI-1 (Inv/Spa TTSS) (167). The importance of the bsa TTSS for B. 
pseudomallei virulence and pathogenesis is not yet entirely clear; however, it has been 
predicted to be an important aspect of B. pseudomallei pathogenesis by contributing to 
cellular invasion and survival in macrophages (102). Furthermore, Stevens et al. showed 
that the bsa TTSS is critical for B. pseudomallei's ability to invade and replicate in J774.2 
murine macrophages and for vacuolar escape following host cell invasion (167). 
The bsa locus encodes homologs of Salmonella and Shigella type III translocators: 
BipB (SipB in Salmonella, IpaB in Shigella), BipC (SipC in Salmonella, IpaC in 
Shigella) and BipD (SipD in Salmonella, IpaD in Shigella). Mutations in BipD showed 
defects in cellular invasion, intracellular replication, endocytic vacuolar escape and actin 
cytosleleton rearrangements (166). BipD has also been shown to be required for 
replication in murine macrophage-like cells. Although there is no direct evidence to 
demonstrate the existence of BipD at B. pseudomallei needle tip, the recently solved 
structure of BipD shows similar overall dumbbell shape with IpaD and LcrV of Yersinia, 
suggesting that BipD probably behaves like its homologs (57, 101).  
Yersinia spp. The pathogenic Yersinia spp. for humans are Y. pestis, Y. 
pseudotuberculosis and Y. enterocolitica (26). Y. enterocolitica and Y. 
pseudotuberculosis cause a  normally self-limiting form of gastroenteritis and are 
transmitted through contaminated food and water (39). Infection in this case is caused by 
invasion of the intestinal tract and intestinal lymphoid tissues (39). Y. pestis, which is 
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transmitted either through a flea bite or through airborne or droplet infection, is the 
causative agent of plague, an acute illness with high mortality (21, 181).  
  Y. enterocolitica and Y. pseudotuberculosis cause gastroenteritis and usually gain 
entry into the host through the fecal-oral route. Like Shigella spp., these bacteria survive 
passage through the stomach and reach the small intestine (43, 181) where they cross the 
mucosal barrier via the M cells and are released at the basal surface of the intestinal 
epithelium (80, 87). Yersinia is capable of limited survival and multiplication within 
macrophages (89). Thus, migrating phagocytes transport the bacteria to local lymphoid 
tissue where they induce inflammation and cause the symptoms of gastroenteritis. These 
bacteria can multiply extracellularly to avoid host immune defenses by blocking 
subsequent uptake by phagocytes via their TTSS. 
 Y. pestis infections are transmitted through flea bites and result in bubonic or 
septicemia plague (21, 181). Typical symptoms of bubonic plague are headache, fever 
and swelling of lymph nodes, whereas in septicemic plague the infection directly 
proceeds to the blood stream without going through the lymph node phase (181). The 
disease can also be transmitted as droplet infection leading to pneumonic plague which is 
an acute pulmonary infection (21). Unlike Y. pseudotuberculosis and Y. enterocolitica, Y. 
pestis travels directly from the blood stream to the liver and spleen where it avoids 
phagocytosis via its TTSS (181). Accumulation of massive numbers of bacteria causes 
necrosis and eventually damages spleen and liver tissue (9, 23).  
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Although the pathogenic Yersinia spp. have different modes of transmission, they all 
require the TTSS for their virulence (44, 181). Proteins called Yop (Yersinia outer 
proteins which are homologs of Shigella Ipa proteins) and LcrV (protective V antigen, 
homolog of Shigella IpaD) are secreted via their TTSS and are essential for Yersinia 
virulence (181). In Y. pseudotuberculosis and Y. enterocolitica, TTSS is not required for 
initial invasion. The bacteria can establish infection in associated lymphatic tissues 
without the TTSS-encoding plasmid (87, 88, 181). Similarly studies showed that Y. pestis 
can establish initial infection in mice without TTSS (87, 88, 181). After initial infection, 
however, the plasmid-cured Yersinia spp. are cleared more rapidly by phagocytes. It was 
later demonstrated that inhibition of phagocytosis depends on the TTSS (82).   
The TTSA in Yersinia spp. consists of a basal body structure located within the 
bacterial membranes and an external needle like the Shigella and Salmonella TTSSs. The 
secreted proteins, the Yops, were first identified a part of Yersinia membrane 
preparations. They are encoded on the virulence plasmid along with TTSA structural 
components like the needle protein YscF and its chaperones YscE and YscG. Expression 
and secretion of the Yops can be induced by a shift in temperature to 37oC coupled with 
Ca2+ depletion in the growth medium (43).  
 Upon host cell contact, the Yersinia TTSA allows direct translocation of virulence 
proteins into the target cell though the translocon pore formed by the translocator proteins 
YopB and YopD (43). Pore formation is aided by another translocator, the needle tip 
protein LcrV (40, 42). LcrV and YopD also have a regulatory role in type III secretion 
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(67, 130). LcrV forms a distinct structure at the tip of the Yersinia TTS needle, where it 
controls insertion of YopB and YopD into the target membrane (129). The functional 
equivalents of YopB, YopD and LcrV in S. flexneri are IpaB, IpaC and IpaD, 
respectively.  
  Pseudomonas aeruginosa P. aeruginosa is an opportunistic pathogen that causes 
severe infections in immuno-compromised individuals and secondary infections in burn 
patients and cystic fibrosis patients (19). P. aeruginosa has a large arsenal of virulence 
determinants including at least six different secretion systems. The TTSSs of P. 
aeruginosa and Yersinia spp. are highly similar and several type III secreted proteins 
within the two systems share considerable sequence homology. Crystal structures of 
Yersinia needle protein YscF bound with its chaperones YscE and YscG and P. 
aeruginosa needle protein PscF bound with its chaperones PscE and PscG were recently 
revealed, and they are structurally very similar (151, 169). Needle tip proteins PcrV and 
LcrV from P. aeruginosa and Yersinia spp., respectively, are genetically exchangeable, as 
are some other secreted proteins, without leading to a loss of function (20, 68). 
Translocators PopB/D (from P. aeruginosa) and YopB/D (from Yersinia spp.) are also 
very similar. 
Bordetella spp. The Bordetella subspecies B. pertussis, B. parapertussis and B. 
bronchiseptica cause respiratory infections in mammals (189). B. pertussis only infects 
humans and is the causative agent of the acute and highly contagious disease known as 
whooping cough or pertussis (47). B. parapertussis causes a pertussis-like syndrome in 
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humans, but it can also infect sheep (47, 48, 149). B. bronchiseptica is 99% identical at 
the DNA sequence level to B. pertussis and, in fact, B. pertussis is considered to be a 
human-adapted variant of B. bronchiseptica (98, 147). Unlike B. pertussis and B. 
parapertussis, B. bronchiseptica infects a wide variety of mammals, including mice, 
guinea pigs and rabbits (46, 74). Approximately 80 to 90% of kennel cough cases are also 
caused by B. bronchiseptica. Pertussis incidence has remained high in recent years, even 
among vaccinated populations (1, 73, 93). Forty million children are infected worldwide 
each year with 300,000 deaths reported, primarily in infants (2, 58). Adolescents and 
adults are a significant reservoir. About 26% of adults with coughing illness show 
evidence of infection (2, 120). 
B. pertussis infects the respiratory epithelium of humans. It is spread by aerosols or 
by direct contact with an infected person. It produces a large number of virulence factors 
that play important roles in its pathogenesis (189). At the first stage of the infection, the 
bacteria colonize the host ciliated respiratory epithelia, causing symptoms that are 
common cold-like such as inflammation of the nose, sneezing, watering eyes, sore throat, 
fever, and cough. The symptoms disappear later but the dry cough of the patient becomes 
more persistent and intense because of the airway ciliated epithelial cells are killed by 
secreted bacterial toxins. The patient struggles for air when the coughing becomes 
extremely intense. The sharp intake of breath sounds like a “whoop” when air is forced 
through the narrowed glottis. Vomiting, cyanosis, and apnea may occur after the cough. 
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The recurrence decreases later, but can last for several weeks. The disease is especially 
serious in infants, causing pneumonia, seizures, encephalopathy and even death.  
The Bordetella TTSS was discovered in late 1990s (189) and it is essential for 
Bordetella pathogenesis (178, 188, 189). The TTSS of B. bronchiseptica is most closely 
related to the Yersinia and P. aeruginosa TTSSs (92). The translocator proteins, BopB 
and BopD of B. bronchiseptica, which are homologs of Yersinia YopB and YopD and P. 
aeruginosa PopB and PopD, share sequence similarity with them (129). LcrV and PcrV 
are orthologs having similar function and similar tip complex structures and their genes 
reside at the same position in the ORFs (22, 76, 77). No LcrV and PcrV homolog was 
found in the Bordetella TTSS (188), however, a 22 kDa protein, Bsp22 (Bordetella 
secreted protein, 22 kDa) is encoded in the operon at the position at which lcrV and pcrV 
are found. Bsp22 has no sequence similarities to any known TTS proteins, including 
LcrV and PcrV. 
Bsp22 is the most abundant Bordetella TTSS secretion protein (188). Although the 
exact function of Bsp22 has not been elucidated, experimental results suggest that it is not 
targeted directly into host cell membranes and may be localized at the bacterial surface 
(188). The effect of Bsp22 on type III associated phenotypes raises the possibility that it 
is involved in targeting TTSS effector proteins into host cells (188). Like LcrV and PcrV, 
it may function by directing translocon pore formation in host cell membranes (65, 69, 
76, 77, 117). Thus, it is possible that Bsp22 is the functional homolog of LcrV and PcrV 
in Bordetella forming the tip complex and controlling TTS.  
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Enteropathogenic E. coli (EPEC) EPEC is one of the leading causes of diarrhea in the 
developing world (34, 59). Their infections are distinguished by adhesion to epithelial 
cells in the small intestine and formation of characteristic lesions having considerable 
cystoskeletal rearrangement and causing damage to mucosal epithelium (34). After initial 
loose adherence to epithelial cells, the EPEC TTSS mediates the contact and 
communication with the host cell. At the site of contact, the epithelium forms an 
elongated pedestal-like structure that harbors the bacterium at its top. The pedestal 
consists of numerous cytoskeletal proteins like actin, α-actinin and ezrin (154). Formation 
of the A/E (attachment and effacement) lesion requires the EPEC adhesin intimin and the 
EPEC TTSS which is composed of a basal structure, a needle and an extension attached 
to the needle called the EspA filament (162). The adhesin binds to Tir (translocated 
intimin receptor) which is translocated through the TTSS and inserted into the target cell 
membrane to serve as the receptor for intimin (108, 109). Type III secreted proteins 
EspA, EspB and EspD are translocated directly into the target cell cytoplasm and are 
required for signal transduction within the host cell (108, 109, 154). Although it forms an 
elongated filament, EspA is most likely the IpaD equivalent while EspB and D are the 
translocon equivalents of IpaB and IpaC, respectively. 
    The TTSA of Shigella is assembled before the initiation of type III secretion. The 
TTS effector and translocator proteins are synthesized and stored in the bacterial 
cytoplasm prior to TTS activation when they are bound to their chaperones for preventing 
premature secretion. The Shigella TTSS is normally activated in vivo by direct contact 
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with host cell, whereupon a rapid burst of secretion takes place. It was not known until 
recently how the TTSA assembly, especially the external needle and tip. Cordes et al. 
have demonstrated that the Shigella needle is a helical assembly of MxiH monomers (38). 
In this study, we determine the atomic structure of needle protein BsaL from B. 
pseudomallei that is the first atomic structure of needle protein monomer, which gives 
insight into the structure and assembly of TTSS needle in general. Structure of IpaD was 
solved later and this previously known translocator protein was found to localize at the 
needle tip before TTS initiation (63, 101). The position of IpaD suggests a direct 
interaction between MxiH and IpaD. We test this interaction by NMR spectroscopy, 
identify specific MxiH residues involved and propose binding model of the needle and 
the tip in this study. It is not known how the signal to activate TTS travels. We also 
investigate the role of tip protein IpaD in TTS activation.  
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CHAPTER 2: Materials and Methods 
 
Materials 
Shigella flexneri 2a strain 2457T was obtained from A. T. Maurelli. Shigella flexneri 
strain SH116 containing the non-polar mxiH null mutations were acquired from Dr. A. 
Allaoui (Université Libre de Bruxelles, Bruxelles, Belgium), Burkholderia pseudomallei 
K96243 genomic DNA was obtained from Dr. D. DeShazer (The United States Army 
Medical Research Institute for Infectious Diseases). Henle (INT) 407 human intestinal 
epithelial cells were from ATCC. These cells were cultured in Eagle’s modified minimal 
essential medium (Fisher Scientific, St. Louis, MO) which was supplemented with 10% 
newborn calf serum (Life Technologies, Gaithersburg, MD) and grown at 37oC with 5% 
CO2. All other culture media and supplies were obtained from Fisher Scientific (St. Louis, 
MO). Taq polymerase and PCR Supermix High Fidelity were purchased from Invitrogen 
(Carlsbad, CA). Oligonucleotide primers were purchased from Integrated DNA 
Technologies (Coralville, IA). The plasmids pET22b, pET15b, Clonables 2x Ligation 
Premix, E. coli NovaBlue cells, E. coli BL21(DE3) and Tuner (DE3) cells were from 
Novagen (Madison, WI). Restriction enzymes were from New England Biolabs (Ipswich, 
MA). 15N-Ammonium chloride (99% pure), 13C6-glucose (99% pure), 15N L-Alanine 
(95-99%), 15N L-Valine (95-99%), 15N L-Leucine (95-99%),  15N L-Isoleucine (95-99%) 
and Deuterium Oxide (99%) were from Cambridge Isotope Laboratories, Inc. (Andover, 
MA). Iminodiacetic acid Sepharose was from Sigma Chemical Company (St. Louis, 
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MO). BME Vitamins solution 100× was from Sigma Chemical Company (St. Louis, 
MO). All other solutions and chemicals were reagent grade and were purchased from 
either Sigma Chemical Co. (St. Louis, MO) or Fisher Scientific (St. Louis, MO).  
 
Buffers and Reagents  
See Appendix A 
 
Bacterial strains, media and growth conditions  
Shigella flexneri strains were grown at 37 oC on Trypticase Soy Agar (TSA) 
containing 0.025% Congo red with appropriate antibiotics for selection of the virulence 
and complementation plasmids. Bacteria that retained the virulence plasmid appeared as 
red colonies on these TSA plates. These colonies were inoculated into Trypticase Soy 
Broth (TSB) containing 50 μg/ml of kanamycin and 100 μg/ml of Ampicillin as 
necessary. TSB broth cultures were grown at 37oC with shaking at 200 rpm.  
 
Cloning of bsaL and bsaL mutants from Burkholderia pseudomallei K96243 
for protein expression 
The B. pseudomallei gene bsaL with a C-terminal truncation (5 amino acids deleted 
from the C-terminus, Δ5) was amplified by PCR directly from the genomic DNA (strain 
K96243). A primer to the 5’ region of bsaL containing a GAGAGA sequence and start 
codon encoded in an NdeI site and a primer to the 3’ region of the gene with a XhoI site 
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was used. The resulting PCR products were digested with NdeI and XhoI and ligated into 
NdeI/XhoI digested pET22b (Novagen) for protein expression, which encodes six tandem 
histidine residues at the C-terminus of the proteins for easy purification. The resulting 
plasmids were transformed into E. coli protein expression strain Tuner (DE3) (Novagen). 
 
Purification of Recombinant protein BsaLΔ5 
Recombinant proteins were purified via a C-terminal His6 tag by nickel-chelation 
chromatography. Briefly, the cells were grown in LB medium at 37oC, 200 rpm. Protein 
expression was induced at OD600 ~0.5 using IPTG for exactly 3 hrs. The cells were 
harvested by centrifugation at 4oC. The cell pellet was resuspended in binding buffer. The 
cells were sonicated and the solution clarified by centrifugation at 20,000g for 20 mins. 
BsaL was purified in its soluble form from the E. coli cytoplasm and thus did not require 
refolding steps. After centrifugation the supernatant fraction was applied to nickel affinity 
iminodiacetic acid sepharose (Sigma) column. The protein was eluted with elution buffer. 
The fractions contatining the protein of interest, as determined by separation on 17% 
SDS-PAGE gel, were collected. Fractions containing recombinant protein were pooled 
and dialyzed into 10mM Na-phosphate, 10mM NaCl, pH 7.0.  
 
Expression of isotopic labeled recombinant BsaLΔ5 in minimal media for 
NMR spectroscopy  
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To obtain uniformly 15N, or 15N,13C-labeled proteins, the E. coli expression strain 
was grown in minimal media supplemented with 15N NH4Cl, or 15N NH4Cl and 
13C-glucose as the sole nitrogen and carbon sources, respectively. After reaching mid-log 
phase, bacteria were induced to produce protein with 1 mM IPTG and grown at 15 oC 
overnight. Bacteria were collected, resuspended in IMAC binding buffer, sonicated, and 
the cellular debris removed by centrifugation. Recombinant protein was purified via His6 
tag by IMAC chromatography as described above. Fractions were pooled and dialyzed 
into appropriate buffers (see above) and the protein concentration was estimated by UV 
absorbance at 280 nm.  
 
NMR spectroscopy and structure determination for BsaLΔ5 
NMR data were acquired at 25 °C on a Bruker Avance 800 MHz and a Varian Inova 
600 MHz NMR spectrometers, both equipped with cryogenic triple-resonance probes. 
Resonance assignments were obtained from 2D 1H–15N HSQC and 1H–13C-HMQC and 
the following 3D datasets: HNCA, HNCO, CBCA(CO)NH, 15N-edited NOESY-HSQC 
(tmix 120 ms) and 13C-edited HMQC-NOESY (tmix 120 ms) (81, 118). NMR data were 
processed using NMRPipe and analyzed using NMRView (56, 99). Inter-proton distance 
restraints were obtained from the NOESY datasets above and were classified based on 
peak volumes into upper bounds of 2.7, 3.5, 4.5 and 5.5 Å and lower bound of 1.8 Å. 
Based on the secondary chemical shifts, the backbone dihedral angles of residues in helix 
α1 and α2 were restrained to Φ=−60(±20)° and ψ=−60(±20)° (185). Additional negative 
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restraints were imposed on non-glycine residues based on the chemical shifts (185). 
Structure calculations and refinement were done as follows. An initial set of 200 
structures were generated by torsion angle dynamics using CYANA, and 100 structures 
with the lowest target functions were further refined by molecular dynamics and 
simulated annealing in vacuo using AMBER7 with the ff99 force field (84). From this, a 
set of 50 structures with the lowest energies were further refined in AMBER7 with the 
generalized Born (GB) potential (50). Twenty structures with the lowest AMBER 
energies were analyzed by PROCHECK and graphics were made using MOLMOL and 
PyMOL (111, 115). 
 
Cloning of mxiH and mxiH mutants for protein expression 
Plasmid pWPSF4mxiH was used as a template for PCR reactions intended to clone 
the mxiH gene for overexpression in E. coli. A primer to the 5’ region of mxiH containing 
a GAGAGA sequence and start codon encoded in an NdeI site and a primer to the 3’ 
region of the gene with a XhoI site was used. The resulting PCR products were digested 
with NdeI and XhoI and ligated into NdeI/XhoI digested pET22b (Novagen) which 
encodes a six tandem histidine residues at the C-terminus of the proteins. Plasmids 
carrying mutation in the mxiH gene were first converted into C-terminal truncations (5 
amino acids deleted from the C-terminus, Δ5) by PCR before being utilized as templates 
for cloning into pET22b for protein expression. The resulting plasmids were transformed 
into the E. coli protein expression strain Tuner (DE3) (Novagen). 
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Purification of Recombinant protein MxiHΔ5 
The protein expression E.coli Tuner (DE3) (Novagen) cells were grown in LB 
medium at 37℃, 200 rpm. Protein expression was induced at OD600 ~0.5 using IPTG for 
exactly 3 hrs. The cells were harvested by centrifugation at 4℃. The cell pellet was 
resuspended in binding buffer. The cells were sonicated and the solution clarified by 
centrifugation at 20,000g for 20 mins. MxiH had to be purified from inclusion bodies in 
the presence of 6 M urea. After sonication, the cell pellet was solubilized in HisBIND 
binding buffer containing 6M urea and centrifuged again to remove insoluble 
components. Recombinant proteins were purified via a C-terminal His6 tag by 
nickel-chelation chromatography as described above. The protein was eluted with 
HisBIND elute buffer containing 6 M urea. The fractions containing the protein were 
determined by separation on 17% SDS-PAGE gel, collected, pooled and then 
step-dialyzed against PBS to gradually remove the urea (4 M, 2 M, 1 M, 0.5 M and 0 M 
urea) at 4℃. The recombinant protein was then dialyzed into 10 mM Na-phosphate, 
10mM NaCl, pH 7.0.  
 
Examining MxiH folding by Circular dichroism spectroscopy 
A Jasco J720 spectropolarimeter (Jasco Inc., Easton, MD) was used for Far UV CD 
spectra and thermal unfolding at 222 nm. Far UV Spectra were recorded from 190nm to 
260nm at a scan rate of 15-20 nm/min using a 0.1 cm path length cell. Spectra were 
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acquired in duplicate and averaged. The thermal-induced unfolding curves were acquired 
using a 0.1 cm path length cell with a temperature ramping rate of 15° C/h. The MxiHΔ5 
concentration was between 40 and 80 μM in all the cases. Deconvolution of CD spectra 
was achieved through analysis with DICHROWEB (104, 188). The unfolding transitions 
were analyzed using Jasco Spectral ManagerTM software. 
 
Expression of isotopic labeled recombinant MxiHΔ5 in minimal media for 
NMR spectroscopy  
To obtain uniformly 15N, or 15N,13C-labeled proteins, expression strain E. coli was 
grown in minimal media supplemented with 15N NH4Cl, or 15N NH4Cl and 13C-glucose 
(see above). After reaching mid-log phase, bacteria were induced to produce protein with 
1 mM IPTG and grown at 15 oC overnight. Bacteria were collected, resuspended in 
IMAC binding buffer, sonicated, and the cellular debris removed by centrifugation. 
Soluble recombinant MxiHΔ5 can be acquired because of low temperature growth. 
Recombinant protein was purified via His6 tag by IMAC chromatography as described 
above. Fractions were pooled and dialyzed into appropriate buffers (see above) and the 
protein concentration was estimated by UV absorbance at 280 nm.  
 
NMR spectroscopy and backbone assignment of MxiHΔ5 
NMR data were acquired at 25 °C on a Bruker Avance 800 MHz NMR spectrometer 
equipped with cryogenic triple-resonance probe. Backbone resonance assignments were 
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obtained from 2D 1H–15N HSQC and the following 3D datasets: HNCA, CBCA(CO)NH 
and HNCACB acquired using a 0.8 mM 15N,13C-MxiH sample as described for BsaL. 
NMR data were processed using NMRPipe and analyzed using NMRView (14, 56, 81, 
99).  
 
Purification of recombinant IpaD 
Recombinant full length IpaD in pET15b with an N-terminal His tag was cloned in 
the lab before and used for protein expression and purification in E. coli protein 
expression strain BL21 (DE3) (Novagen). Recombinant proteins were purified by 
nickel-chelation chromatography as described above. After sonication, the solution was 
clarified by centrifugation at 20,000g for 20 min and the supernatant was applied to the 
nickel-chelation column. The fractions containing IpaD were determined by separation on 
12% SDS-PAGE gel, collected, pooled and then dialyzed into 10mM Na-phosphate, 
10mM NaCl, pH 7.0 NMR buffer.  
 
NMR chemical shift mapping of the interaction between MxiH and IpaD 
Uniformly 15N-labeled MxiH and unlabeled IpaD were dissolved in NMR buffer (10 
mM sodium phosphate, pH 6.0, 10 mM NaCl, 10% D2O, and 90% H2O). NMR data were 
acquired at 25 °C on a Bruker Avance 800 MHz spectrometer fitted with a cryogenic 
triple-resonance probe and a Z-axis pulse field gradient. NMR data were processed using 
NMRPipe and analyzed using NMRView (56, 99). Chemical shift mapping was done by 
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acquiring two-dimensional 1H-15N HSQC at MxiH: IpaD molar ratios of 0.5, 1, 2, 4, and 
8. Both IpaD and MxiH were dialyzed into the same buffer prior to titration to assure that 
the chemical shift changes were only due to protein-protein interactions and not to 
changes in solution condition upon mixing. 
 
Cloning of mxiH mutants for expression in S. flexneri mxiH null strain SH116 
The plasmid pRKmxiH was used as a template in PCR reactions to create all the 
mxiH mutants. The PCR primers used are listed in the Appendix. Using pRKmxiH as a 
template, point mutations were made by means of inverse PCR using High fidelity PCR 
supermix and specific primers. The primers have a GAGAGA sequence, a restriction site 
and 18 bases past the point mutation. The following PCR conditions were used: [95oC, 2 
min] (1 cycle); [95oC, 50 s; 54oC, 45 s; 72oC, 4 min] (35 cycles); [72oC, 10 min] (1 
cycle). The PCR products were digested with appropriate restriction enzymes, 
intramolecularly ligated and then electroporated into S. flexneri SH116. For inducible 
expression of mxiH in SH116, the gene was subcloned into the pKT1001 (171) where the 
NdeI site was removed and the EcoRI-HindIII polylinker region replaced with that from 
pWPsf (146). The resulting plasmid was named pRK2mxiH.  
 
Preparation of mxiHΔ5 Mutants for Expression in E. coli Tuner (DE3) 
To produce MxiH in its monomeric form, five residues were genetically deleted from 
the C terminus of the protein. The resulting mutant mxiHCΔ5 genes were copied from the 
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corresponding plasmids containing mxiH mutants created as described above by PCR. A 
5'-primer containing GAGAGA, an NdeI restriction site, and the first 18 bases of mxiH 
and a 3'-primer containing GAGAGA, a XhoI restriction site, and the last 18 bases of 
mxiH excluding the stop codon and the last 5 amino acids were used. The PCR product 
was digested with NdeI and XhoI and ligated into correspondingly digested pET22b, and 
the ligated product was transformed into E. coli NovaBlue. Double-stranded sequencing 
was performed on each new mutant mxiHCΔ5 gene to confirm that only the desired 
mutation was incorporated. The resulting plasmids were used to transform E. coli Tuner 
(DE3) (Novagen). This strain was used for purification of the mutant MxiHCΔ5 proteins as 
described above.  
 
Cloning of ipaD mutants for expression in S. flexneri ipaD null strain SF622  
The plasmid pwpsf4ipaD was used as a template in PCR reactions to create all the 
ipaD mutants. The PCR primers used are listed in the appendix. Using pwpsf4ipaD as a 
template, point mutations were made in a similar way as described above for making 
mxiH mutant. The PCR products were digested with appropriate restriction enzymes, 
intramolecularly ligated and then electroporated into S. flexneri SF622 (146).  
 
Cloning of ipaD mutants for protein expression  
Plasmid pwpsf4ipaD was used as a template for subsequent PCR reactions designed 
to generate IpaD mutants. A primer recognizing the 5’ region lacking the first 38 amino 
 46
acids of ipaD, but having a GAGAGA sequence and start codon encoded within an NdeI 
site together with a primer to the 3’ region deleting the last 11 residues of the ipaD gene, 
but containing a stop condon and an XhoI site was used. The resulting PCR products were 
digested with NdeI and XhoI and ligated into NdeI/XhoI digested pET22b (Novagen), 
which encodes six tandem histidine residues (His6Tag) at the C-terminus of the proteins. 
Plasmids carrying the ipaD gene or mutated ipaD genes were first converted into 
N-terminal and C-terminal truncations by PCR before being used as templates for cloning 
into pET22b for protein expression. The resulting plasmids were transformed into E. coli 
protein expression strain BL21(DE3) (Novagen). 
 
Western blot analysis 
The obtained proteins were electrophoretically separated by standard acrylamide 
SDS-PAGE gel (17% for BsaL and MxiH; 12% for IpaD; 10% for IpaB and IpaC). After 
that, the proteins were electrophoretically transferred from SDS-PAGE gels to PVDF 
membranes using a Trans-Blot SD Semi-Dry Transfer Cell (Bio-Rad Inc., Hercules, CA) 
for 45 min at a constant voltage of 15V. After transfer, the membrane was incubated in 
blocking buffer (LI-COR Biosciences) with shaking for at least 1 hour at room 
temperature. The blocked membrane was then incubated with a solution containing 
primary antibodies. The primary antibody was allowed to incubate with the membrane 
room temperature for at least one hr with gentle shaking. Following this incubation step, 
the membrane was rinsed three times with PBS containing 0.1%Tween-20 for 5 min. 
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Membrane was incubated in the secondary antibodies for 1 hr at room temperature with 
continuous shaking. The membrane was then rinsed three times with PBS containing 
0.1%Tween-20 for 5 min, and then rinsed with PBS. The blot was examined in a 
ODYSSEY Infrared Imaging System (LI-COR Biosciences) until a suitable image was 
obtained. 
 
Assay of overnight Ipa secretion in Shigella mutants   
Wild type and mutant strains were inoculated into 10 ml Trypticase Soy Broth (TSB) 
with 50 μg/ml kanamycin and 100 μg/ml ampicillin. The cultures were incubated 
overnight at 37oC at 200 rpm. The cultures were clarified by centrifugation and 
trichloroacetic acid (TCA) was added to the culture supernatant to a final concentration of 
10%. The proteins were incubated on ice for 30 min to allow for affinity binding of the 
proteins to the solid state matrix. The beads were then collected by centrifugation at 
10,000 rpm in a SS34 rotor. The resulting pellet was washed once with 10 ml 5% TCA 
followed by two washes with 20 ml ice-cold 100% acetone. Proteins were resuspended in 
50 μl SDS-PAGE sample buffer and 15 μl of this sample was separated on 10% 
SDS-PAGE gel and visualized by Coomasie blue staining. 
 
Assay of Congo red (CR) induction of TTSS secretion in Shigella 
Bacteria were inoculated into 10 ml TSB with appropriate selective antibiotics and 
incubated with shaking at 37oC. Upon reaching an O.D.600 ~ 1.0, 1 ml of the bacteria were 
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collected by centrifugation and then resuspended in 500 μl cold phosphate buffer at pH 
7.2. After adding 5 μl Congo red solution (3.5mg/ml in phosphate buffer), the bacteria 
were incubated at 37oC for 12 min without shaking. After centrifugation, the bacterial 
pellet was discarded and the supernatant was clarified by passing through Spin-X® 
columns. SDS sample buffer and DTT were added and 15 μl of the sample was separated 
on a 10% SDS-PAGE gel. 
 
Growth and maintenance of Henle 407 epithelial cells, preparation of cell 
culture plates 
Henle 407 intestinal epithelial cells (ATCC# CCL6) were grown in Minimal 
Essential Medium Eagle (Modified) containing Earle’s Salts, L-glutamine, sodium 
bicarbonate, and phenol red (MEME). This medium was supplemented with 1% antibiotic 
solution (10,000 U/ml penicillin and 10 mg/ml streptomycin in 0.9% NaCl, Sigma 
Chemical Co., St. Louis, MO) and 10% newborn calf serum (MEME-CS). The cells were 
grown in 5% CO2:95% air at 37oC and fed by replacement of media twice a week with 
MEME-CS. Cells were allowed to grow to confluence and then passaged as follows:  
The cells in one 25 cm2 flask were rinsed once with 3 ml of solution A and treated with 3 
ml 0.25% trypsin (GIBCO-BRL, Grand Island, NY) for 5 min to allow the monolayer to 
lift from the flask. The trypsinized flasks were agitated to free the cells from the substrate, 
and this solution was pipetted up and down ten times to produce a single-cell suspension. 
Three ml of MEME-CS was added to the single cell suspension, and 1 ml of this solution 
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was added to each of six new 25 cm2 flasks containing 5 ml of MEME-CS. The newly 
passaged cells were replenished with fresh MEME-CS the next day. In order to prepare 
cell culture plates for invasion assays the above procedure was followed up to the trypsin 
incubation step. During the trypsin incubation, 500 μl of MEME-CS was added to each 
well of a sterile 24 well tissue culture plate. Once the monolayer was observed to lift from 
the surface of the flask with gentle agitation, 3 ml of MEM-CS was added and the 
solution pipetted vigorously to produce a single cell suspension of epithelial cells. Two 
drops of the cell suspension was added to each of the 24 wells, stirred in a figure eight 
motion, and placed in the tissue culture incubator at 37oC for 12 hours prior to initiation 
of experiments. This places approximately 5Х104 cells per well. 
 
Assay of bacterial entry into cultured epithelial cells  
S. flexneri invasion of Henle 407 cells was monitored using a standard 
gentamycin-protection assay as described (145). Pre-confluent monolayers of Henle 407 
cells were seeded into 24-well plates and grown overnight at 37oC. SH116 harboring the 
desired mxiH-containing plasmid or SF622 harboring the desired ipaD-containing 
plasmid was grown in trypticase soy broth (TSB) containing ampicillin and kanamycin to 
an A600 of 0.4 to 0.6. The bacteria were then added to the wells and incubated with the 
cells for 30 min at 37oC to allow for invasion. After incubation, free bacteria were 
removed by aspiration and the cells washed with MEM containing 5% calf serum and 50 
μg/ml gentamycin. The cells were incubated in the final gentamycin wash for 1 hour to 
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kill adherent, non-internalized bacteria and rinsed with MEME. After aspiration of all the 
MEME, cells were lysed and immobilized by overlaying them with 250 μl 0.5% agarose 
in water. The agarose was then overlaid with 0.5% agar containing 2× LB medium. After 
overnight incubation at 37oC, internalized bacteria formed subsurface colonies that were 
quantified. 
 
Contact-mediated hemolysis of sheep red blood cells  
Contact-mediated hemolysis was measured as described by Blocker et al. (16).  
Briefly, S. flexneri were grown overnight on TSA-Congo red plates and a single red 
colony was used to inoculate TSB.  The bacteria were grown to mid-log phase at 37oC, 
200 rpm. The bacterial cells were collected by centrifugation at 4oC at 4000 rpm and 
resuspended in PBS at 1/40th the original volume. Sheep red blood cells (RBCs) were 
washed and resuspended in PBS at a concentration of 1 x 1010 cells/ml.  RBCs and 
bacteria (50 μl each) were added to wells of microtiter plates and the plates centrifuged at 
2200 × g for 15 min at 25oC. The plates were then incubated at 37oC for 1.5 hrs.  The 
cells were resuspended by adding 90 μl cold PBS and the plates were centrifuged again at 
2200 × g at 15oC for 15 min. The supernatant fraction (100 μl) was transferred to a 
second microtiter plate and the absorbance of the released hemoglobin measured as the 
absorbance at 545 nm using a mitrotiter plate reader (μQuant plate reader, Biotech 
Instruments, Highland Park, VT). 
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Purification of long TTSA needle from S. flexneri 
     mxiH gene was cloned into the IPTG inducible plasmid pRK2 and was over 
expressed in mxiH null strain (mxiHpRK2/SH116). Over expression of mxiH gave rise to 
assembly of extremely long needles up to 500nm. This strain was inoculated into TSB 
containing kanamycin, ampicillin and 1mm IPTG and grown overnight at 37oC. The cells 
were harvested by centrifugation, and resuspended in 1/30th volume ice-cold phosphate 
buffered saline (PBS), pH 7.2. The cell suspension was passed vigorously through a 
syringe with an 18 gauge needle to shear the needle complexes. The supernatant 
containing the needle complexes was clarified by centrifugation at 4oC and 4000 rpm for 
10 min first and then at 13000 rpm for 15 min twice. 
 
Visualization of purified needles by transmission electron microscopy (TEM) 
A 5 μl drop of the needle sample was placed on Parafilm. Carbon-formvar coated 
copper grids (Electron Microscopy Sciences) were floated on the sample with the 
carbon-coated side placed face down on the sample. Grids were incubated with the 
sample in this manner for 5 min to allow for adsorption of the sample. The grids were 
then washed twice with 20 μl PBS and 20 μl dH2O. The grids prepared above were 
floated on a 10 μl drop of 2% uranyl acetate in water for negative staining. Staining for 
10-12 minutes gave the best contrast for visualization. After staining, the grids were 
blotted on edge against a Whatman filter paper to remove excess uranyl acetate. The grids 
were allowed to dry completely overnight before visualization under the microscope. 
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Electron micrographs were taken using a 1200 JEM 1200 EX II transmission electron 
microscope (Microscopy and Analytical Imaging Center, University of Kansas) at an 
electron acceleration voltage of 80 KeV for visualization.  
 
Fluorescence polarization (FP) spectroscopy for measuring the interaction of 
IpaD with FITC-DOC 
Fluorescein-4-isothiocyanate-labeled DOC (FITC-DOC) was prepared by Dr. 
Ken Stensrud in Department of Chemistry, University of Kansas. FP measurements were 
obtained using a Beacon fluorescence polarimeter (Panvera Corp.). FP measures the 
rotational diffusion of a fluorescent molecule. Large molecules rotate slower than small 
ones resulting in higher polarization value. When fluorescent FITC-DOC binds to 
nonfluorescent IpaD the molecular volume of the fluorescent species will increase, thus 
an increased mP value. A constant concentration of FITC-DOC (30-50 nM) in PBS was 
mixed with increasing concentrations of IpaD (μM range). The change in FP was 
monitored as a change in millipolarization units (ΔmP) and was plotted as a function of 
IpaD concentration. 
 
Immunofluoresence microscopy for the presence of IpaD at Shigella surface 
S. flexneri were grown to early log phase in TSB with or without 2.5 mM DOC. The 
bacteria were collected by centrifugation at 4000 rpm for 10 min and washed twice with 
PBS. They were resuspended in 4% (v/v) formaldehyde in PBS and were dry fixed to 
slides. After being blocked with 1% BSA in PBS, the bacteria were labeled with 
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monoclonal mouse anti-IpaD antibodies and Alexa Fluor 488 goat anti-mouse IgG. 
Imaging was performed using a Yokugawa-type spinning disk confocal attached to an 
Olympus IX-81 microscope, alternately using either the 473-nm laser line with a 505 to 
530 band-pass emission filter (Alexa 488) or a 561-nm laser line with a 580-520 
band-pass emission filter (Alexa 568).  
 
NMR spectroscopy and backbone assignment of IpaD38-321 
37 amino acids at the N-terminus and 11 amino acids at the C-terminus of IpaD were 
truncated by PCR using pwpsf4ipaD as template. A primer to the 5’ region containing a 
GAGAGA sequence and start codon encoded in an NdeI site and a primer to the 3’ region 
of the gene with a XhoI site was used. The resulting PCR products were digested with 
NdeI and XhoI and ligated into NdeI/XhoI digested pET22b (Novagen) for protein 
expression. The resulting plasmids were transformed into E. coli protein expression strain 
BL21 (DE3) (Novagen).  
Uniformly 2H-, 15N-, 13C-labeled proteins were obtained by growing the expression 
strain E. coli BL21 (DE3) in minimal media with D2O instead of H2O supplemented with 
15N-NH4Cl and 2H-, 13C-glucose as the nitrogen and carbon sources. An overnight culture 
of E. coli BL21 (DE3) with pET22bIpaD38-321 in LB was harvested and the bacteria were 
inoculated into minimal media with D2O in the next morning. After grown at 37 oC for 45 
min, the bacteria were induced to produce protein with 1 mM IPTG and grown for 
another 6 hours before harvest. The bacteria were then collected, resuspended in IMAC 
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binding buffer, sonicated, and the cellular debris removed by centrifugation. Recombinant 
protein was purified via His6 tag by IMAC chromatography as described above. Fractions 
were pooled and dialyzed into 10 mM sodium phosphate pH 7.0 with 10 mM NaCl buffer 
and the protein concentration was estimated by UV absorbance at 280 nm.  
Uniformly 2H-, 15N-, 13C-labeled proteins were dissolved in NMR buffer (10 mM 
sodium phosphate pH 7.0, 10 mM NaCl, 10% D2O, and 90% H2O). NMR data were 
acquired at 30°C on a Bruker Avance 800 MHz spectrometer fitted with a cryogenic 
triple-resonance probe and a Z-axis pulse field gradient. NMR data were processed using 
NMRPipe and analyzed using NMRView. Backbone resonances were assigned using 
1H-15N TROSY and TROSY-based HNCA and HNCACB.  
 
NMR chemical shift perturbation for the interaction between IpaD and 
deoxycholate (DOC) 
Uniformly 15N-labeled IpaD38-321 was purified and dissolved in NMR buffer (10 mM 
sodium phosphate, pH 7.0, 10 mM NaCl, 10% D2O, and 90% H2O). NMR 1H-15N 
TROSY data were acquired at 30 °C on a Bruker Avance 800 MHz spectrometer fitted 
with a cryogenic triple-resonance probe and a Z-axis pulse field gradient. NMR data were 
processed using NMRPipe and analyzed using NMRView. Two-dimensional 1H-15N 
TROSY spectrum of free IpaD was collected, and then spectra of IpaD bound with DOC 
were acquired at DOC: IpaD molar ratios of 1, 3 and 6. Chemical shift mapping was done 
by overlaying the 1H-15N TROSY spectra described above.  
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CHAPTER 3: Solution Structure of Monomeric BsaL, the Type III Secretion 
Needle Protein of Burkholderia pseudomallei  
 
Introduction 
B. pseudomallei is the causative agent of mellioidosis, an illness that can manifest 
itself in humans as an acute, sub-acute or chronic infection (52). Mellioidosis is endemic 
to southeastern Asia and northern Australia, and has the potential for global spread (52). 
Asymptomatic infections can progress to clinical mellioidosis (51) and acute and 
sub-acute disease can give rise to B. pseudomallei latency and the potential for delayed 
relapse (31, 49). B. pseudomallei and B. mallei (glanders) are considered bioterrorism 
threats due to their world-wide availability and their ability to be transmitted by aerosol 
(167). Both organisms are on the CDC and USDA select agent list and require special 
handling due to the dangerous human and zoonotic infectious they can cause. 
Many Gram-negative bacterial plant and animal pathogens, including a number of 
potential bioterrorism agents, use type III secretion systems (TTSSs) as their key 
virulence factors for the subversion of target eukaryotic cell functions (96). A better 
understanding of all aspects of type III secretion would be useful for improving both 
public health and national security. B. pseudomallei possesses at least one genetic region 
that encodes a TTSS resembling that of the plant pathogens Ralstonia solanacearum and 
Xanthomonas spp (167). A separate TTSS (the bsa locus) encoded within a recently 
identified B. pseudomallei pathogenicity island is similar to those encoded by the Shigella 
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virulence plasmid (the Mxi/Spa TTSS) and Salmonella pathogenicity island SPI-1 
(Inv/Spa TTSS) (167). The importance of the Bsa TTSS for B. pseudomallei virulence 
and pathogenesis is not yet entirely clear, however, Stevens et al. showed that it is critical 
for invasion of B. pseudomallei and replication in J774.2 murine macrophages and for 
vacuolar escape within host cells (167). 
The TTSA of Gram-negative bacterial pathogens is a macromolecular protein 
assembly that allows physical contact between the pathogen and its target cell (96). The 
TTSA functions like a syringe, wherein bacterial TTSS translocator proteins are delivered 
directly into the host cell membrane to form a translocon pore through which other 
proteins are then translocated into the host cytoplasm (18). A major component of the 
TTSA is an external needle that extends from a basal structure and forms a conduit for 
translocating proteins into the target cell. For B. pseudomallei, the TTSA needle is formed 
by the assembly of multiple copies of a single protein, BsaL, which is a homologue of 
MxiH in Shigella, PrgI in Salmonella, YscF in Yersinia, and other putative type III needle 
proteins (see Figure 3). 
The Shigella MxiH needle, for which more extensive data are available, consists of a 
tube-like structure with a 70 Å outer and a 25 Å inner diameter channel that extends 500 
Å from the base of the TTSA (38). A similar structure exists at the surface of Salmonella, 
Yersinia and P. aeruginosa (103, 119, 142). The Shigella needle monomer (MxiH) is 
arranged in a helical pattern with 24 Å pitch and 5.6 units per turn (37). Recent 
mutational analysis has implicated MxiH in controlling the induction of TTS in Shigella  
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BsaL                 MSNPPTPLLADYEWSGY---LTGIGRAFDDGVKDLNKQLQDAQANLT 
MxiH                 MS--------VTVPNDD-WTLSSLSETFDDGTQTLQGELTLALDKLA 
PrgI                 MP---------TSWSGY---LDEVSAKFDKGVDNLQTQVTEALDKLA 
EprI                 MA----------DWNGY---IMDISKQFDQGVDDLNQQVEKALEDLA 
YscF                 MSN-----FSGFTKGNDIADLDAVAQTLKKPADDANKAVNDSIAALK 
PscF                 MAQ-----IFN---PNPGNTLDTVANALKEQANAANKDVNDAIKALG 
 
BsaL                 K--NPSDPTALANYQMIMSEYNLYRNAQSSAVKSMKDIDSSIVSNFR 89 
MxiH                 K--NPSNPQLLAEYQSKLSEYTLYRNAQSNTVKVIKDVDAAIIQNFR 83 
PrgI                 A--KPSDPALLAAYQSKLSEYNLYRNAQSNTVKVFKDIDAAIIQNFR 80 
EprI                 T--NPSDPKFLAEYQSALAEYTLYRNAQSNVVKAYKDLDSAIIQNFR 79 
YscF                 D--TPDNPALLADLQHSINKWSVIYNISSTIVRSMKDLMQGILQKFP 87 
PscF                 GTDNADNPALLAELQHKINKWSVIYNINSTVTRALRDLMQGILQKIG 86 
 
 
Figure 3. The TTSS needle proteins of different bacteria show sequence 
conservation, especially within the core structure where helix α1 and α2 of BsaL are 
located. The conserved P-X-X-P motif that forms the inter-helical turn in BsaL is boxed. 
The residues at the interface of the BsaL helix α-1 and α-2, which are involved in 
stabilizing the structure of the core domain, are conserved among bacterial species 
(marked in red). Conserved and identical residues are in red. Sequences are from 
Swiss-Prot, and the bacterial species and its associated needle protein are: B. 
pseudomallei (BsaL), S. flexneri (MxiH), S. typhimurium (PrgI), E. coli O157:H7 (EprI), 
Y. pestis (YscF), and P. aeruginosa (PscF). 
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with related findings reported for YscF of Yersinia pestis (107, 174). These reports 
implicate the TTSA needle and associated extracellular proteins in sensing host cell 
contact and the transmission of TTS signals. 
Sequence alignment of the needle proteins from various bacterial species shows 
higher sequence conservation in the middle part of the proteins relative to their 
amino-terminal regions (Figure 3). Secondary structure predictions indicate a 
predominantly α-helical secondary content with some possible β-strand structure (54, 
107). Circular dichroism (CD) spectroscopy confirms the α-helical content of the Shigella 
needle protein MxiH as well as PrgI and BsaL (54). Because of the potential for needle 
monomer self-association or aggregation, handling recombinant needle proteins in vitro 
must be considered carefully (150). Previous studies have shown that short C-terminal 
deletions render at least some TTSA needle proteins unable to polymerize on the bacterial 
surface (107). Such deletions yielded soluble and monomeric forms of MxiH and PrgI, as 
well as BsaL (54). These needle protein monomers retain all of their native secondary 
structure and tend to display readily reversible thermal unfolding (54). 
The three-dimensional atomic structure of BsaL was the first to be solved for any of 
the TTSA needle proteins and this finding is the subject of this chapter. The 
high-resolution solution structure of the monomeric needle protein of B. pseudomallei, 
BsaL lacking its five C-terminal residues (BsaLΔ5), was determined by nuclear magnetic 
resonance (NMR) spectroscopy (191). This protein monomer is composed of two 
well-defined helices within the central portion of the protein's primary sequence, and 
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flanked by residues that appear to adopt a partial α-helical conformation. The NMR data 
rule out the possibility of an internal β-strand and provide insight into the possible sites of 
the monomer–monomer interactions that are likely to be needed to form the B. 
pseudomallei Bsa TTSA needle. The atomic structure of BsaL and its sequence homology 
with other TTSA needle proteins suggest potentially unique structural dynamics that 
could be linked with a universal mechanism for control of type III secretion in diverse 
Gram-negative bacterial pathogens. 
 
Results 
Preparation of BsaLΔ5 for structural analysis. Recombinant B. pseudomallei BsaLΔ5 
lacking five C-terminal residues and possessing a His6 C-terminal tag was purified by 
Ni2+-chelation chromatography as described in Chapter 2. CD spectroscopy indicated that 
BsaLΔ5 is rich in α-helical secondary structure (approximately 70%) and is similar, in 
this respect, to MxiHΔ5 and PrgIΔ5 (Dr. Roma Kenjale, unpublished results) (54). The 
2D 1H–15N heteronuclear single quantum coherence (HSQC) spectrum of recombinant 
BsaLΔ5 (Figure 4) showed a narrow 1H chemical shift range with well-dispersed peaks, 
consistent with the likelihood that this protein contains a high degree of α-helical 
structure. Because of the high degree of solubility and apparently well-defined structural 






Figure 4. The 2D NMR 1H–15N correlation spectrum (HSQC) of the recombinant 
15N-labeled BsaLΔ5. The HSQC showed well-dispersed peaks and a narrow proton 
chemical shift range of about 1.5 ppm, suggesting a predominantly helical structure. 
Assignments are indicated, and the insert shows the blow-up of the central portion of the 
spectrum (boxed) (191). 
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NMR spectroscopy of BsaLΔ5. Analysis of 3-D HNCA, CBCA(CO)NH, HNCO, 
13C-edited HMQC-NOESY, and 15N-edited NOESY-HSQC experiments afforded near 
complete sequence-specific backbone and side-chain resonance assignments of BsaLΔ5 
(81, 118). Ser2 and three residues at the C terminus, Met77–Asp79, are missing from the 
1H–15N HSQC spectrum due to exchange broadening and could not be assigned. The His 
residues in the C-terminal His6-tag are disordered, as determined by secondary chemical 
shifts in the random coil range, and 15N and 13C NOESY peaks that showed only strong 
intraresidue nuclear Overhauser effect (NOE) peaks. Analysis of the Hα, Cα, Cβ, and C′ 
secondary chemical shifts suggested the presence of two well-defined helices in BsaLΔ5 
(Figure 5) (185). This was further confirmed by the NOE patterns, such as 
, (where i=residue number), , and  










The central portion of BsaLΔ5 forms a two-helix bundle. Structure calculation and 
refinement using CYANA and AMBER yielded well-converged structures (Figure 6a), 
with low energies and low distance and dihedral angle restraint violations (Table 1). A 
total of 716 NOE-derived distance restraints and 67 φ and 33 ψ dihedral angle restraints 
were used in the structure calculation (Table 1). PROCHECK analysis of the ensemble of 
20 low energy structures showed that more than 99% of the residues are within the 
allowed region of the Ramachandran plot (Table 1). The central portion of BsaLΔ5, 




Figure 5. Secondary chemical shift index. Secondary chemical shifts obtained by 
subtracting the random coil 13Cα, 1Hα, 13Cβ, and 13C′ chemical shift values from those 




Figure 6. NMR structures of BsaLΔ5. (a) Stereo view of the 20 lowest energy NMR 
structures of BsaLΔ5 showing residues Asp27–Ser72. Residues Lys30–Asn68 form the 
well-defined core domain of BsaLΔ5. The rest of the molecule does not adopt a single 
conformation. (b) Ribbon diagram of the lowest energy NMR structure of BsaLΔ5, 
showing the residues that form the hydrophobic contacts at the interface of helix α1 and 
α2. (c–e) Surface representations showing the polar residues that line the surfaces of the 
core domain of BsaLΔ5. The side-chain functional groups of residues on the surface are 
colored as follows: amides blue, carboxyls and hydroxyls red, methylenes green, and the 
methionine sulfur atoms orange (191).  
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Table 1. Number of restraints for BsaLΔ5 (residues M1-I85) and the core 
domain (residues K30-N68), and structure statistics for the 20 low energy 
structures of BsaLΔ5. 
 
 K30-N68 M1-I85  K30-N68 
A. Number of 
restraints 





582 716 RMSb deviation from the 









127 193 All heavy atoms (Å) 0.88 
Medium range 
(2≤|i−j|≤4) 
217 267 Violation analysis  
Long range 
(|i−j|>4) 





67 100 Maximum distance (Å) 0.28 
Phi 34 67 Energies  
Psi 33 33 Mean AMBER energy 
(kcal/mol) 
-3183 
   Mean restraint energy 
(kcal/mol) 
37 
   Deviation from idealized 
geometry 
 
   Bond lengths (Å) 0.0100±0.0001
   Bond angles (deg.) 2.43±0.02 
   PROCHECK statistics  
   Most favorable (%) 87.2 
   Additionally allowed (%) 12.3 
   Generously allowed (%) 0.4 
   Disallowed (%) 0.1 
 
a i,j=residue number. 
b RMS, root-mean-square. 
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needle protein monomer, with two well-defined helices joined by an ordered, four-residue 
PSDP turn. More than 80% of the assigned NOEs and nearly all of the long-range NOEs 
are found within this core domain, yielding an average of about 15 restraints per residue 
(Table 1). Helix α1 has five helical turns and spans residues K30–N46. This is followed 
by a highly ordered linker composed of Pro47-Ser-Asp-Pro, which immediately connects 
with the seven-turn helix α2 spanning residues T51–N68. 
The helix α1-α2 interface is stabilized by hydrophobic interaction. The BsaLΔ5 core 
domain is stabilized by hydrophobic interactions (Figure 6), mediated by residues that are 
also conserved among needle proteins (Figure 3). The hydrophobic side of the 
amphiphatic helix α1 forms direct contact with the hydrophobic side of the second helix 
(Figure 6b). The two helices pack at an angle of −66°, and the interface is formed by the 
hydrophobic interactions of L32, L36, A39, and L43 on helix α1 with Y63, M60, I59, 
Y56, L53, and A52 on helix α2. The aromatic rings of Y56 and Y63 are stabilized by 
hydrophobic contacts. The Y56 ring is sandwiched between the hydrophobic side-chains 
of L43 and M60, and forms additional contacts with the methylene groups of Q40 and 
Q67. Similarly, the Y63 ring is wedged between L36 and the methylene groups of R67 
with additional contacts to side-chains of L32 and Q64. 
The surface of the core domain is lined with polar residues. The surfaces of the 
core domain are dominated by polar groups (Figure 6c–6e). One side is lined with polar 
residues: Q40, Q37, N33 on helix α1 and Q57, S61, Q64, and N68 on helix α2 (Figure 
6c). In addition, the hydroxyl groups of Y56 and Y63 are pointed toward the surface and 
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contribute to the overall polarity of this side (Figure 6c). N68 is conserved among needle 
proteins (Figure 3), however, it does not participate in hydrophobic contacts at the helix 
α1-α2 interface, suggesting that it might be involved in functions other than stabilizing 
the core domain. The other side of BsaLΔ5 (Figure 6d) is also lined with polar residues: 
K30, D31, K34, Q35, D38, N42, and K45 on helix α1 and T51, N55, Q57, and the 
hydroxyl group of Y66 on helix α2. The linker between helix α1 and α2 is also polar, 
comprised of S48 and D49 and near to N46 at the end of helix α1 (Figure 6e). The polar 
nature of the helix-turn-helix core domain of BsaLΔ5 suggests that this domain is 
solvent-exposed in the needle apparatus. 
Significance of two trans proline residues at the interhelical turn of BsaLΔ5. The 
two proline residues located at the center turn of BsaLΔ5, P47 and P50, are in a trans 
conformation, as evidenced by strong NOEs from the proline Hδ protons to the Hα 
protons of the preceding residues, N46 and D49, respectively. The trans conformation of 
these two Pro residues constrains the orientation of the two helices, α1 and α2, so that 
they must be positioned next to each other. That is, they must assume a structure that is 
very close to the final global fold of the core domain of the needle protein. These two Pro 
residues are highly conserved among TTSA needle proteins in diverse bacterial species 
(Figure 3). The constraining action of these two Pro residues suggests a role in the folding 
of all these needle protein homologues and may provide an explanation for the reversible 
unfolding of the protein in vitro (54). 
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Terminal residues flank the core domain and are likely to be in partial-helical 
conformations. The first seven residues of BsaLΔ5 are unstructured. These residues have 
no apparent secondary structures from chemical shifts and show only intraresidue NOEs. 
Based on sequential NOE patterns, the three Pro residues in this region, P4, P5, and P7, 
are all in trans conformation, with a minor cis conformation also observed for P4. The 
regions flanking the well-defined core domain of BsaLΔ5, A10 to G28 at the N terminus 
and S71 to I84 at the C terminus, are partially ordered. They exhibit medium-range NOE 
patterns that are more characteristic of α-helical structures. For example, residues from 
L9 to G28 and S71 to I84 showed a consistent pattern of  NOEs with 
weaker intensities compared to the corresponding  NOEs found in helix 
α1 and α2. There are also sequential  NOEs found from L8 to G28, and 
for some of the residues between S71 to I84, again with weaker intensities compared to 
those found in helix α1 and α2. It is not possible to ascertain the presence (or absence) of 
weak  NOEs between S71 and I84 with the available NMR data due to 
spectral overlap. The NOE patterns suggest the regions flanking the core domain are not 














No β-hairpin in BsaLΔ5. In the absence of high-resolution structural data for the 
needle proteins of the TTSA, the Salmonella flagellar filament, FliC, was used to predict 
the structure of the needle proteins of the TTSA (54, 107). This secondary structure 
prediction suggested the presence of a β-hairpin in the needle proteins corresponding to 
residues Y63-Q70 of BsaLΔ5. This is not supported by the NMR data. The secondary 
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chemical shifts, NOE patterns, and NMR structure indicate that Y63–Q70 forms the 
C-terminal part of helix α2 and cannot be in a β-hairpin conformation. Based on the 
sequence similarity, other needle proteins are also likely to fail to have a β-hairpin in this 
region (Figure 3). 
 
Discussion 
The bacterial TTSA consists of a basal body that spans the inner and outer 
membranes of Gram-negative bacteria and an external needle formed by the 
polymerization of multiple copies of a single type of protein into a tube-like helical 
structure (18). These substructures give rise to an apparatus that is capable of delivering 
bacterial proteins into eukaryotic cells for the subversion of normal cellular functions. 
Upon assembly, the needle apparatus forms a 25 Å diameter channel that is used for 
translocating bacterial effector proteins into the host cell membrane and cytoplasm. For 
high-resolution structural determination of monomeric needle proteins, it was necessary 
to consider potential problems that could arise from the intermolecular protein–protein 
interaction of recombinant needle subunits. Such issues probably contribute to the lack of 
high-resolution structures for any TTSS needle protein until recently. Deletion of the 
C-terminal five residues of the needle proteins MxiH from Shigella, PrgI from 
Salmonella, and BsaL results in the production of monomeric forms of these proteins (54, 
150). Monomers produced in this way retain extensive native secondary structure, as 
determined by biophysical characterization, thus allowing high-resolution structure 
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determination of these needle protein monomers. The central portions of the sequences of 
several needle proteins show strong sequence conservation (Figure 3) and all of those 
purified as monomers appear to have very similar secondary structures that are rich in 
α-helical content (Dr. Roma Kenjale, unpublished results). It was expected that structure 
determination for any one of the needle proteins would provide a significant contribution 
to the current understanding of how needle protein structure correlates with its 
biophysical properties, its polymerization into type III secretion needles, and possibly its 
role in pathogenesis. 
Recombinant BsaLΔ5 showed ideal characteristics needed for NMR-based structure 
determination. BsaLΔ5 displayed near-millimolar solubility and well-dispersed peaks in 
the 2D 1H–15N HSQC spectrum (Figure 4), making it highly suitable for NMR structural 
characterization. Analysis of secondary chemical shifts clearly identified two 
well-defined helices (Figure 5) and further analysis of the NOESY datasets yielded a 
good number of distance restraints (Table 1), which allowed for atomic-level structure 
determination with good structural statistics. 
As a monomer, the central portion of BsaLΔ5 forms a well-structured, two-helix 
bundle. The first seven residues are completely disordered and the regions flanking the 
well-structured core domain are partially ordered. This is reflected in a higher number of 
distance restraints, averaging about 15 restraints per residue within the central region. In 
contrast, the flanking regions showed medium-range NOEs that are characteristic of 
α-helical structures. The NMR structure of BsaLΔ5 (Figure 6) supports the CD data 
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showing that this needle protein is predominantly α-helical. PrgI and MxiH appear to 
have similar structures (55, 182). The data presented here do not, however, support the 
previous suggestion that there may be a β-hairpin within the C-terminal half of these 
needle proteins. The core domain is stabilized by hydrophobic interaction and the surface 
is lined with polar residues, suggesting that this part of the needle protein is solvent 
exposed when incorporated into the needle apparatus.  
The two-helix bundle is a common structural feature of many proteins, and a search 
using DALI yielded at least 52 proteins that are structurally homologous to the core 
domain of BsaLΔ5 (95) (Table 2). These proteins contain helix-turn-helix structures that 
can be superimposed with the core domain of BsaLΔ5 with a root-mean-square deviation 
(RMSD) of 2.0 Å or better. Table 2 contains a wide variety of proteins, including 
membrane proteins, enzymes, chaperones, and transcription factors found in eukaryotes, 
bacteria, and viruses. These proteins can be involved in cell adhesion, gene regulation, 
signaling, and metabolism. What is noteworthy is the lack of sequence identity among 
these proteins. Of the 52 proteins, 42 had sequence identity below 10% with the highest 
identity being a designed protein (23%). There is structural homology with another TTSS 
protein, YscE, of Y. pestis which had a backbone RMSD value of 1.9 Å and 14% 
sequence identity with the BsaLΔ5 core domain (144). YscE is a TTSS chaperone that, 
together with another protein, YscG, forms a stable ternary complex with the Yersinia 
needle protein, YscF. This interaction prevents premature polymerization of the needle 
protein in the bacterial cytoplasm (169). 
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Table 2. List of proteins that are structurally homologous to the core domain of 
BsaL (residues K30-N68) obtained using the search program DALI. The core 
domain of BsaL showed a structural homology with the TTS chaperone YscE 









Functional Class Protein Name, Source 
1H6O 1.1 9 Telomere binding Telomeric Repeat Binding Factor 1, Homo sapiens 
2MHR 1.2 10 Oxygen binding  Myohemerythrin, Themiste zostericola 
1P68 1.4 23 Designed   De Novo Designed Protein, Synthetic 
1RJ1 1.4 0 Protein binding  Invertase Inhibitor, Nicotiana tabacum 
1R9S 1.5 15 Transcription NA-Directed RNA Polymerase II, Synthetic 
1U89 1.5 10 Structural   Talin 1 Fragment, Mus musculus    
1EYY 1.6 5 Oxidoreductase   Aldehyde Dehydrogenase, Vibrio harveyi 
1FOH 1.6 9 Flavin           Phenol Hydroxylase, Trichosporon cutaneum 
1BL8 1.7 5 Membrane   Potassium Channel Protein Mutant, Streptomyces 
lividans 
1EGU 1.7 3 Lyase           Hyaluronate Lyase, Streptococcus pneumoniae  
1KMI 1.7 5 Signaling     Chemotaxis Protein CheY, Escherichia coli 
1ORQ 1.7 2 Membrane   Fab Light Chain 6e1 Fab Heavy Chain, Mus musculus 
1RW9 1.7 3 Lyase           Chondroitin Ac Lyase, Arthrobacter aurescens  
1SKV 1.7 5 Unknown Hypothetical 7.5 KDa Protein, Sulfolobus virus-like 
particle  
1UJW 1.7 10 Transport Vitamin B12 Receptor, Escherichia coli 
1EK9 1.8 10 Membrane   Outer Membrane Protein TolC, Escherichia coli 
1NKD 1.8 7 Transcription  N Rop Protein, Escherichia coli  
1U7L 1.8 5 Structural    Vacuolar ATP Synthase Subunit C, Saccharomyces 
cerevisiae 
1VCS 1.8 13 Transport Vesicle Transport Homolog, Mus musculus 
1YC9 1.8 17 Membrane   Multidrug Resistance Protein (VceC), Vibrio cholerae   
1DOV 1.9 10 Cell Adhesion    Alpha-Catenin Fragment, Mus musculus  
1FPO 1.9 5 Chaperone  Chaperone Protein Hscb (Hsc20) Mutant, Escherichia 
coli 
1I4D 1.9 10 Signaling   Arfaptin 2 Fragment (Partner of Rac), Homo sapiens 
1LRE 1.9 8 Cell surface  Receptor-Associated Protein Fragment, Homo sapiens 
1QSD 1.9 18 Chaperone  ß-Tubulin Binding Post-Chaperonin Cofactor, 
Saccharomyces cerevisiae 
1UPG 1.9 10 Transcription Transcriptional Repressor Tram, Agrobacterium 
tumefaciens 
1VMG 1.9 12 Hydrolase       Hypothetical Protein, Sulfolobus solfataricus  
1WDZ 1.9 10 Signaling   Insulin Receptor Substrate P53 Fragment, Homo sapiens 
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1XVH 1.9 11 Cell adhesion  Hypothetical Protein, Staphylococcus aureus 
1Y2O 1.9 10 Signaling   Bai1-Associated Protein 2 Isoform 1, Homo sapiens 
1YF2 1.9 3 Hydrolase 
regulator  
Type I Restriction-Modification Enzyme, 
Methanocaldococcus jannaschii  
1ZHC 1.9 2 Unknown Hypothetical Protein, Helicobacter pylori 
1ZW0 1.9 14 Chaperone      Type III Secretion Protein YscE, Yersinia pestis 
2A65 1.9 5 Transport   Na(+):Neurotransmitter Symporter, Aquifex aeolicus    
1CXZ 2.0 3 Signaling   His-Tagged Transforming Protein RhoA, Homo sapiens 
1D2M 2.0 7 Hydrolase        Excinuclease Abc Subunit B (UvrB), Thermus 
thermophilus 
1DL2 2.0 8 Hydrolase Class I Alpha-1,2-Mannosidase, Saccharomyces 
cerevisiae 
1GRJ 2.0 5 Transcription  N Grea Transcript Cleavage Factor, Escherichia coli   
1GW5 2.0 10 Endocytosis      Adaptor-Related Protein Complex Subunit, Mus 
musculus    
1GWC 2.0 3 Transferase       Glutathione S-Transferase TSI-1, Aegilops tauschii  
1HUW 2.0 7 Hormone Human Growth Hormone Mutant, Homo sapiens    
1K04 2.0 12 Transferase Focal Adhesion Kinase 1 (Fadk 1), Homo sapiens 
1KON 2.0 11 Unknown Protein YebC, Escherichia coli 
1LF6 2.0 5 Hydrolase Glucoamylase, Thermoanaerobacterium spp. 
1LNQ 2.0 2 Metal transport  Potassium Channel Related, Methanothermobacter spp. 
1SF9 2.0 13 Unknown Hypothetical Protein, Bacillus subtilis 
1X8Z 2.0 13 Protein binding  Invertase/Pectin Methylesterase Inhibitor, Arabidopsis 
spp. 
1YKE 2.0 10 Gene regulation RNA Polymerase II Mediator Complex Protein MED7, 
Saccharomyces cerevisiae 
1Z1W 2.0 0 Hydrolase  Tricorn Protease Interacting Factor F3, Thermoplasma 
spp. 
2B7M 2.0 3 Endocytosis Exocyst Complex Component Exo70, Saccharomyces 
spp   
2BDE 2.0 16 DNA Binding   Cytosolic IMP-GMP 5'-Nucleotidase, Legionella 
pneumophila 
2C2A 2.0 5 Transferase   Histidine Kinase, Thermotoga maritime 
 
*RMSD, Root-mean-square deviation of the backbone atoms. 
†ID, Percent sequence identity between the fragment of the matched protein that aligned 
with the core domain of BsaL (K38-N68). 
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CHAPTER 4: Identification of the MxiH Needle Protein Residues 
Responsible for Anchoring Invasion Plasmid Antigen D (IpaD) to the Type 
III Secretion Needle Tip  
 
Introduction 
The pathogenesis of Shigella flexneri requires a functional type III secretion 
apparatus (TTSA) to provide a conduit for injecting host-altering effector proteins into the 
membrane and cytoplasm of the target cell (45). Type III secretion systems (TTSSs) are a 
shared virulence determinant for many Gram-negative animal and plant pathogens.They 
are used to subvert normal cellular functions (24, 92). The Shigella TTSA is composed of 
a basal body that spans both bacterial membranes and an exposed needle that is a polymer 
of MxiH. The needle is 50 nm in length, has an outer diameter of 7.0 nm, and possesses 
an inner channel that is 2.0-3.0 nm in diameter (17, 38).  
Invasion plasmid antigen D (IpaD) was recently discovered to localize to the tip of 
the TTSA needle where it controls type III secretion (TTS) and directs the insertion of the 
translocator proteins IpaB and IpaC into the host cell membrane (63, 146). From its 
position at the TTSA needle tip, IpaD is initially responsible for recruiting and stably 
maintaining IpaB to this site in the presence of bile salts (137). This step in Shigella TTS 
will be discussed more thoroughly in Chapter 5, however, it is clear in this series of 
events that interactions between IpaD and MxiH that are responsible for tip complex 
stabilization are critical for Shigella pathogenesis (63, 137).  
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The high resolution crystal structures of MxiH and IpaD were recently reported (55, 
100). MxiH monomers possess a helix-turn-helix head group with an elongated 
C-terminal helix (55). The head group is stabilized by hydrophobic contacts between 
residues at the interface between the two helices that flank a central PSNP loop (55). The 
MxiH structure resembles the B. pseudomallei needle monomer (BsaL) structure which 
was the first in this protein class to be determined.  
The TTSA needle appears to pack by polar contacts between the individual MxiH 
monomers with the PSNP loop facing outward and upward relative to the central channel 
(55). In contrast to MxiH, IpaD has a more complex structure that resembles a dumbbell 
in its shape (101). IpaD has a central coiled-coil that defines the handle of the dumbbell 
and is flanked at each end by distinct N- and C-terminal domains (101). This shape 
defines the tip proteins as a unique class and appears to be important for IpaD localization 
at the tip of the needle (62, 63). Based on in silico modeling of the Yersinia tip complex 
protein LcrV on the reconstructed Shigella MxiH needle tip, the LcrV N-terminal 
globular domain and the C-terminal end of the coiled-coil both have a role in docking 
LcrV on the needle (55). Although the IpaD structure shows that its N-terminal domain 
can mimic a MxiH molecule and thereby serve to chaperone the C-terminal coil in the 
bacterial cytoplasm by preventing the premature association of MxiH and IpaD, how 
IpaD docks onto the MxiH needle could not be resolved even after the structure of the 
two proteins became available (101). Nevertheless, interactions in addition to those that 
dictate needle assembly would be expected to be involved in maintaining IpaD at the 
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needle tip. Therefore, the structural basis for the interaction between MxiH and IpaD was 
explored. 
The data presented here show that specific residues within the MxiH head group are 
located at the MxiH-IpaD interface. These residues are needed for stable maintenance of 
IpaD at the TTSA needle tip but are distinct from those needed for needle assembly. The 
work presented here provides an initial step in understanding this important 




MxiH binding to IpaD. IpaD localizes at the tip of the Shigella TTSA needle (63). 
Although it has been shown that the C-terminal coil of IpaD is required for its 
maintenance at the MxiH needle tip, no such data are available to directly demonstrate the 
structural role of the TTSA needle protein in the IpaD-MxiH interaction. Using 
fluorescence polarization (FP) analyses, we were able to detect in vitro protein-protein 
interactions between MxiH and IpaD (Figure 7). IpaD was labeled with fluoresesin 
maleimide (FM) at C322, which provides the only free thiol in IpaD. C322 is 10 residues 
away from the IpaD C-terminus, and it is this portion of IpaD that mediates its stable 
association with the Shigella TTSA needle tip (63). The initial polarization value for IpaD 
was 247.9 ± 0.7 mP, a high value that is consistent with the attachment of a fluorescent 




Figure 7. Interaction of IpaD with MxiH. FM-labeled IpaD (200 nM) was 
incubated with MxiHCΔ5 (closed circle) or IpgC (open circle). The change in the 
polarization value (ΔmP) of the FM-IpaD was measured as a function of MxiH 
concentration. Addition of anti-IpaD IgG resulted in a maximum ΔmP of 30.8 (n = 3) 
(190). These experiments were performed with the help of Dr. W. D. Picking.
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measured increase of 21.2 mP whereas no change was seen upon the addition of the 
negative control protein IpgC, the chaperone for the translocator proteins IpaB and IpaC 
(Figure 7). Because the maximum mP achieved by the addition of anti-IpaD IgG is 30.8 
mP, the change in polarization upon addition of MxiH appears to represent a significant 
change based on the fact that its mass is only one fourth that of IpaD. The fact that a 
detectable change is observed most likely stems from the previous observation that IpaD 
association with the MxiH needle involves the C-terminus of IpaD and this is near where 
the FM labeling occurs (63). The FP data presented here thus indicate that IpaD and 
MxiH interactions are detectable in vitro. Furthermore, the binding data suggest that the 
two proteins have an apparent dissociation constant (Kd) in the micromolar range (Figure 
7). 
Identification of MxiHCΔ5 residues interacting with IpaD by NMR spectroscopy. 
We used NMR chemical shift mapping to identify the MxiHCΔ5 residues that contact IpaD 
based on the reasoning that the MxiHCΔ5-IpaD interaction should result in changes in the 
NMR resonances of MxiHCΔ5. Because the smaller MxiHCΔ5 (8.3 kDa) is more amenable 
to NMR characterization compared with IpaD, we titrated unlabeled IpaD into 15N-labeled 
MxiHCΔ5 and monitored the changes in the chemical shifts of MxiHCΔ5 by acquiring 
several 15N HSQC spectra with increasing amounts of IpaD. Indeed, there are NMR peaks 
of MxiHCΔ5 that shift upon adding IpaD (Figure 8). We assigned the resonances of free 
MxiHCΔ5 using standard three-dimensional NMR experiments (Figure 9). Assigning the 




Figure 8. Identification of MxiH Residues That Interact with IpaD by NMR 
Spectroscopy (continued). A) Titration of 15N-MxiHCΔ5 with increasing amounts of 
unlabeled IpaD. Overlay of six protein-nitrogen correlation spectra (15N HSQC) at 
various MxiHCΔ5:IpaD molar ratios (black, 0; red, 0.5; green, 1.0; blue, 2.0; yellow, 4.0; 
magenta, 8.0). The actual MxiHCΔ5: IpaD concentrations used are as follows (in µM): 
black (800:0), red (320:160), green (200:200), blue (110:220), yellow (60:240), and 
magenta (30:250). Peaks with * could not be assigned because they did not show 
cross-peaks on the 13C plane in the three-dimensional data sets (HNCA, CBCACONH, 
and HNCACB) used in the backbone assignments. The insert shows an expansion of a 
crowded region of the 15N HSQC. MxiHCΔ5 contains a single tryptophan, and the side 
chain Trp-10 Nε1 resonance (at 15N = 129.375 and 1H = 10.076) was not perturbed upon 
addition of IpaD and therefore is not shown. B) The HSQC peaks of individual residues 
affected by IpaD binding are shown separately for clarity. MxiH residues that are 
perturbed by IpaD are mapped on the surface of the crystal structure of MxiH (Protein 
Data Bank code 2CA5). C) The back side view of panel B is shown (190). 
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Figure 9. 3D NMR experiments of free MxiHCΔ5. A) HNCA spectra of MxiH, 
shown as 13C, 1H strips for residues W10-L15. Each strip shows the Cα of the current 
residue and the Cα of the preceding residue. HNCA, together with CBCA(CO)NH and 
HNCACB, confirms the backbone assignments for W10-L15. The backbone assignments 
for the rest of the protein were obtained in a similar manner. B) CBCA(CO)NH spectra of 
MxiH, shown as 13C, 1H strips for residues W10-L15. CBCA(CO)NH shows the Cα and 
Cβ of the preceeding residue together with backbone amide of the current residue. C) 
HNCACB spectra of MxiH, shown as 13C, 1H strips, for residues T11-S16. Each strip 
shows the Cα and Cβ of the preceeding and current residue and the amide resonances of 
the current residue. The Cα and Cβ have opposite phases (shown as black and red peaks). 
The spectra were acquired using a 0.8 mM 15N, 13C-MxiHCΔ5 at 800 MHz and 25°C (190). 
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ppm in the center of the two-dimensional 15N HSQC spectra (Figure 8A). The narrow 
proton chemical shift range is consistent with the predominantly α-helical structure of 
MxiHCΔ5. The disordered N-terminal 19 residues in the X-ray structure of MxiHCΔ5 most 
likely also contribute to the broad peaks between 7.8-8.5 ppm (55). Nevertheless, using 
three-dimensional HNCA, CBCA(CO)NH, and HNCACB (Figure 9), we assigned 62 of 
78 backbone amides of MxiHCΔ5.  
Upon adding IpaD to labeled MxiHCΔ5, many of the MxiHCΔ5 chemical shift peaks 
were perturbed. Further addition of IpaD changed peak positions even more, indicating 
that binding was in fast exchange NMR time scale. This behavior is consistent with the 
micromolar binding affinity obtained in fluorescence polarization experiments. The peaks 
of the PSNP loop residues (N40, S42, N43, and Q45) and the head group residues (L26, 
L30, L32, A33, L34, Y50, Q51, L54, and Y57) clearly shifted to a different part of the 
spectrum (Figure 8). The latter set of residues form a contiguous surface (Figure 8B and 
8C) when mapped on the X-ray crystal structure of MxiHCΔ5 (55). The side chains of L30, 
L34, Y50, Q51, L54, and Y57 form one face of the contiguous surface (Figure 8B), and 
the side chains of L26, L32, and A33 are on the "backside" (Figure 8C). Therefore, it is 
likely that the main site of IpaD binding on MxiHCΔ5 is the surface formed by residues in 
the contiguous surface and the PSNP loop. 
In Vivo analysis of MxiH mutant strains. NMR chemical shift mapping of the 
MxiH homolog from Burkholderia pseudomallei, BsaL, showed that the BsaL residues 
equivalent to MxiH L30, L54, and Y57 are part of the needle monomer-monomer surface 
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contact (141). Therefore, we propose that there are two overlapping sites on MxiH: one 
for IpaD binding and another for MxiH binding and that the L30-L54-Y57 surface (see 
Figure 8B) is common for both IpaD and MxiH binding. Hence, MxiH mutations were 
designed to disrupt IpaD binding while attempting to maintain the MxiH-MxiH 
association. Thus, not all residues that showed chemical shift changes upon IpaD addition 
were mutated. Residue Q51 was previously mutated (Table 3) and it had no effect on 
IpaD association with the Shigella surface (63, 107). Mutation of S42 was also shown to 
have no effect on MxiH function (107). Residues that are not conserved among needle 
proteins from different pathogens were not mutated since the side chain composition at 
these positions does not appear to be critical. This was the case for L26, L32, A33, and 
Q45 (55, 182). Where NMR assignments were lacking, mutations were not introduced 
because subsequent interpretation of the data would be difficult. Most importantly, those 
residues that appeared to have a role in the packing of MxiH monomers were not mutated 
because the mutations would be expected to disrupt needle assembly (141). Therefore, we 
did not mutate the MxiH residues L30, L54, Y57 which appear to be necessary for 
MxiH-MxiH contacts. In contrast, L47 showed minor chemical shift changes; however, it 
is next to the PSNP loop and near Y50. Likewise, it is invariant among the needle 
proteins of Shigella, Salmonella, and Burkholderia. In the MxiH monomer structure, the 
side chain of L47 (which is on helix 2) is oriented toward the surface of the two-helix 
bundle (Figure 8B) (55). This suggests that L47 is not needed in maintaining the 
hydrophobic core that dictates the overall fold of the MxiH structure and thus may be  
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Table 3. MxiH mutants used in this study  
 
Mutantsa Reason for selectionb 
MxiHL34A Minor chemical shift, somewhat conserved 
MxiHN40A Major chemical shift, somewhat conserved 
MxiHN43A Major chemical shift, conserved 
MxiHN43K Same as above, introduces bulky charged group 
MxiHL47A Minor chemical shift, highly conserved 
MxiHL47D Same as above, introduces charged group 
MxiHY50F Major chemical shift, highly conserved, preserves phenyl ring 
MxiHY50L Same as above, eliminates phenyl ring, preserves hydrophobic side chain 
MxiHQ51A 
Previously shown to retain function and does not interfere with IpaD 
localization at needle tip (63, 107) 
a) Mutations were introduced into full-length MxiH for complementation analysis using 
S. flexneri SH116. A MxiHCΔ5 version with a C-terminal His6 was then made for 
L47A, L47D, Y50F, Y50L, and Q51A for generation of recombinant protein in E. 
coli BL21 (DE3). The recombinant protein was used for analyzing interactions with 
FM-labeled IpaD by fluorescence polarization  
b) Chemical shifts refer to the NMR shifts described in Fig. 11. Conserved is a measure 
of the sequence conservation seen among MxiH and its needle protein homologues 
from Salmonella typhimurium (PrgI) and B. pseudomallei (BsaL)  
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involved in IpaD binding. Therefore, L47 was mutated to determine its potential role in 
anchoring IpaD to the Shigella TTSA needle tip. N40 and N43 of the MxiH PSNP loop 
and L34, L47, and Y50 of the contiguous surface were selected for site-specific mutations. 
Mutations were introduced to give MxiHL34A, MxiHN40A, MxiHN43A, MxiHN43K, MxiHL47A, 
MxiHL47D, MxiHY50F, MxiHY50L, and MxiHQ51A (Table 3). For residues N43, L47, and 
Y50, two substitutions per residue were introduced to explore the importance of side chain 
composition in needle tip association. MxiHN43A and MxiHN43K were designed to test the 
impact of replacing a polar residue with either a smaller nonpolar or a somewhat larger 
and positively charged residue. MxiHY50F maintained the phenyl ring while MxiHY50L 
maintained a hydrophobic side chain. In contrast, the MxiHL47A mutation decreased the 
length of the hydrophobic side chain while MxiHL47D changed the polarity of the region 
by adding a negative charge. 
The ability of the MxiH mutants to complement the S. flexneri mxiH null strain 
SH116 was assessed using established phenotypic assays with the data summarized in 
Table 4 (63). First, invasion of Henle 407 cells and contact-mediated hemolysis were used 
to assess the proper introduction of IpaB/IpaC translocons into targeted cells, which is 
dependent upon IpaD localization to the TTSA needle tip (17, 63, 137, 146). Second, 
overnight secretion of Ipa proteins was used to provide a measure of functional needle 
formation. Excessive overnight secretion can provide a measure of the loss of IpaD at the 
needle tip because an ipaD null mutant and IpaD mutants that fail to localize at the needle 
tip are known to be hypersecretive (63, 122, 146). Lastly, induced (rapid) secretion of Ipa  
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Invasionc Hemolysisd Uninduced/induced 
secretione 
Wild type +/+ 100 ± 7f 100 ± 14g +/++ 
mxiH null –/– <1 ± 1 2 ± 1 –/– 
MxiHCΔ5 –/– 0 ± 0 0 ± 0 –/– 
ipaD null –/+ 0 ± 0 0 ± 0 +++/– 
MxiHL34A +/+ 44 ± 10 22 ± 5 +/++ 
MxiHN40A +/+ 82 ± 5 17 ± 3 +/++ 
MxiHN43A +/+ 77 ± 7 25 ± 3 +/++ 
MxiHN43K 50%/+ 8 ± 3 2 ± 2 ++/+ 
MxiHL47A –/+ <1 ± 1 2 ± 1 +++/– 
MxiHL47D –/+ <1 ± 1 1 ± 0 +++/– 
MxiHY50F 20%/+ 57 ± 8 9 ± 2 ++/+ 
MxiHY50L 50%/+ 51 ± 6 12 ± 2 ++/+ 




Table 4. Phenotype of MxiH mutants (continued) 
a) Wild type is pRKMxiH/SH116, the mxiH null mutant strain is SH116, and the ipaD 
null mutant is SF622. All other strains are SH116 transformed with the plasmid encoding 
one of the MxiH point mutants as described here.  
b) Surface localization of IpaD and MxiH was determined by immunofluorescence 
microscopy. At least 100 bacteria in each of three randomly selected fields were counted 
(n = 3). In most cases, surface localization was either seen on all bacteria or none in a 
given field. For some mutants, reduced overall fluorescence was visualized and a reduced 
number of bacteria were seen with IpaD on their surfaces. In these cases, an approximate 
percentage of cells having surface IpaD is given.  
c) Invasion is relative to pRKMxiH/SH116 ± S.D. (n = 3).  
d) Contact-mediated hemolysis is relative to pRKMxiH/SH116 ± S.D. (n = 3).  
e) Uninduced secretion is the secretion of TTSS proteins (IpaB and IpaC) into the culture 
medium during overnight growth. Induced secretion is the secretion of TTSS proteins by 
bacteria after a 30-min incubation with Congo red (63, 107).  
f) Raw value of invasion of Henle cells by pRKMxiH/SH116 is 237 ± 15 colonies.  
g) Raw value of contact-mediated hemolysis of pRKMxiH/SH116 is 2.8 ± 0.02 (A545).  
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proteins into culture supernatants upon adding Congo red was examined because this 
activity is lost in ipaD null mutants and it thus correlates with the loss of IpaD at the 
TTSA needle tip (63). In contrast, loss of needle polymerization results in no Ipa secretion 
or detection of MxiH on the bacterial surface (63, 107, 137). Therefore, if a MxiH mutant 
fails to maintain IpaD at the needle tip, there will be no invasion, no contact hemolysis, 
uncontrolled overnight secretion, a loss of Congo red-induced Ipa protein secretion, and 
no IpaD detected on the bacterial surface (63). Because the MxiH mutants were designed 
not to interfere with MxiH polymerization, however, MxiH should be detected on the 
Shigella surface and overexpression of mxiH should give rise to the formation of long 
versions of the TTSA needle that can be sheared from the bacterial surface and visualized 
by transmission electron microscopy (TEM) with negative staining. The phenotypes of 
the mxiH mutant strains are presented in Table 4. 
N40 and N43, which are part of the PSNP loop, were mutated because they showed 
some of the largest chemical shift perturbations upon addition of IpaD (Figure 8). 
Previous results concluded that the polar residues in the PSNP region can tolerate 
mutation to Ala and still give rise to functional needle tip complexes (107). Likewise, 
although contact-mediated hemolysis was reduced for N40A and N43A, these mutations 
had minimal effects on needle tip complex formation as determined by surface 
localization of IpaD (Table 4). In contrast, mutation of N43 into the somewhat larger and 
basic residue Lys decreased needle tip complex formation (Table 4). The decreased ability 
for this strain to stably maintain IpaD at the needle tip (50% reduction) resulted in a lack 
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of secretion control as well as loss of the ability for Shigella to invade Henle 407 cells 
and lyse erythrocytes (Table 4). Thus, the PSNP loop interacts directly with IpaD and is 
required for the formation of the MxiH-IpaD tip complex.  
Adjacent to the PSNP loop, L34, L47, Y50, and Q51 form a contiguous surface on 
the two-helix bundle and were perturbed upon adding IpaD (Figure 8B). Although the 
chemical shift of L34 was small, it lies within the contiguous surface, suggesting that L34 
could contribute to IpaD binding. Indeed, the L34A mutation partially reduced invasion 
and hemolysis, suggesting that it has a minor effect on IpaD binding to the needle. Q51A 
has been characterized and found to have only a partial defect in secretion control, 
indicating a minor deficiency in IpaD affinity for MxiH (107). In contrast to L34 and 
Q51, mutation of L47 and Y50 had significant consequences with regard to S. flexneri 
phenotype and the observed interactions with IpaD in vitro. It is also noteworthy that L47 
and Y50 are highly conserved among the needle proteins from different species. Both 
L47A and L47D mutants abolished IpaD surface presentation, resulting in a noninvasive, 
nonhemolytic strain that completely lacks secretion control (Table 4). These mutations, 
however, did not affect MxiH-MxiH interactions since they were capable of needle 
formation as detected by immunofluorescence microscopy (Table 4) as well as electron 
microscopy (see Figure 10A for L47D). When recombinant MxiHCΔ5 proteins possessing 
mutations at L47 were prepared so that their interaction with FM-labeled IpaD could be 
monitored in vitro by FP analysis, a detectable decrease in binding to IpaD was observed 




Figure 10. Transmission electron micrographs of sheared needles from S. flexneri 
SH116 expressing MxiHL47D (A) or MxiHY50F (B) from a pRK2 plasmid. Needles were 
sheared from bacteria in log phase by passage through a 25-gauge needle. The needles 
were applied to carbon-coated Formvar grids and negatively stained with 2% uranyl 
acetate (190). 
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Table 5. Association of MxiH mutant proteins with FM-IpaD by fluorescence 
polarization.  
 
Mutant protein Maximum observed ΔmPa Apparent dissociation constantb 
Wild type 24.6 ± 2.0 0.48 
MxiHL47A 7.8 ± 0.7 2.47 
MxiHL47D –1.7 ± 0.9 ND 
MxiHY50F 7.6 ± 0.4 1.30 
MxiHY50L 12.8 ± 0.8 2.48 
MxiHQ51A 24.7 ± 0.9 0.65 
 
a The change in polarization is presented in millipolarization units  
b The apparent dissociation constant was determined using 25 nM FM-IpaD using 
Sigmaplot®  
ND – not determined 
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at the needle tip. Y50 is near L47 on helix α2 and its phenyl ring forms a network of 
hydrophobic contacts with residues on helix α1 that contribute to the stability of the 
two-helix bundle (55). The hydroxyl group of Y50 is pointed toward the MxiH surface 
and is not involved in any intramolecular contacts (55). Therefore, the Y50 hydroxyl 
group is not required in stabilizing the overall fold of the MxiH two-helix bundle. 
Structurally, a Phe or Leu in this position would be expected to maintain the hydrophobic 
core and the overall fold of the two-helix bundle, yet Y50 is invariant among the needle 
proteins of Shigella, Salmonella, and Burkholderia. Thus, the mutations Y50F and Y50L 
were made and the phenotypes of each mutant strain determined (Table 4). Y50L and 
Y50F resulted in a 50-80% reduction in IpaD surface presentation, which negatively 
affects invasion, hemolysis, and secretion control (Table 4). Both Y50F and Y50L, 
however, form stable needles in vivo when examined by either immunofluorescence 
(Table 4) or electron microscopy (Figure 10). As with L47, the recombinant MxiHCΔ5 
proteins possessing the Y50 mutations were purified to examine their binding interaction 
with FM-labeled IpaD. Indeed, like the L47 mutants, the Y50 mutants have a noticeable 
increase in the apparent dissociation constant, with Y50F being 3-fold higher and Y50L 
being 5-fold higher (Table 5). Thus, although the hydroxyl group has a role in the stable 
maintenance of IpaD at the TTSA needle tip, the hydrophobic interaction mediated by the 
phenyl ring appears to contribute more substantially to the in vitro interaction between 
IpaD and MxiHCΔ5. Taken together, the data indicate that key residues of the contiguous 




Figure 11. Model of MxiH-IpaD binding. Left) The two-helix bundle of MxiH (green, 
α1 and α2) can be superimposed with helices H1 and H2 of IpaD (gray) with a Cα root 
mean square deviation of 3.2 Å. Right) The MxiH-IpaD binding interface is expanded, 
and the figure is rotated by 180° relative to the orientation in the left panel. The side 
chains of MxiH residues (L30, L34, Y50, L54, Y57) that experienced NMR chemical 
shift perturbation upon titration of IpaD as well as L47 are all oriented toward helices H3 
and H7 of IpaD. The loop residues (N40, S42, and N43, red) also showed chemical shift 
perturbations (190).  
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and function of the MxiH-IpaD tip complex (Figure 11). 
 
Discussion 
Previously, we have shown that the C-terminal coil of IpaD is required for its 
association with the MxiH needle and that the N-terminal globular domain is external to 
the needle (63). Modeling using the recently solved individual crystal structures of MxiH 
and IpaD, however, was unable to explain how IpaD docks at the top of the MxiH needle 
other than that the orientation is likely to be the same as that predicted for LcrV (55, 101, 
129). Based on the MxiH and IpaD crystal structures, Johnson et al. proposed a model for 
the interaction of MxiH with IpaD based on the fact that the IpaD N-terminal domain is 
structurally similar to MxiH and therefore could serve as an intramolecular cytoplasmic 
chaperone that prevents the interaction of IpaD with MxiH prior to IpaD’s recruitment to 
the bacterial surface (101). The IpaD N-terminal helices H1 and H2 pack together in such 
a way that the MxiH structure can be superimposed on the MxiH two-helix bundle (α1 
and α2) with a Cα root mean square deviation of 3.2 Å (Figure 11, left). This structural 
similarity is striking considering that the Cα root mean square deviation between the two 
needle homologs BsaL and MxiH is also 3.2 Å (182). This suggests that IpaD has a 
built-in surface that complements the size and shape of that portion of MxiH that is 
responsible for maintaining IpaD at the TTSA needle tip. The NMR chemical 
shift-mapping results provide the first biochemical data to support such a model in that the 
MxiH residues that are perturbed upon adding IpaD appear to form a contiguous face 
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(Figure 11, right) that may actually be contacting a yet unidentified surface on IpaD and 
this interaction is blocked in the bacterial cytoplasm by the presence of the IpaD N 
terminus. MxiH residues within the region capable of interacting with IpaD would include 
the side chains of L47 and Y50, which upon mutation in this study abolished or severely 
perturbed IpaD localization. Furthermore, in this model, the MxiH PSNP loop would 
directly contact helices H3 and H7 of IpaD. Such an interaction would be sterically 
impossible based upon the crystal structure of full-length IpaD unless the N-terminal 
domain were moved away upon tip complex assembly. Indeed, the chemical shifts of 
N40, S42, and N43 demonstrate an interaction between the PSNP loop and IpaD does 
exist, suggesting that it is possible that the N-terminal domain moves away upon tip 
complex assembly. Unfortunately, at this time it is impossible to predict how the N 
terminus (helix H1-H2') "swings away" during tip complex assembly to permit IpaD 
docking atop the MxiH needle. Because it has been postulated that the needle channel 
cannot accommodate a fully folded IpaD, it is possible that it travels through the needle 
channel in a partially unfolded manner and that refolding at the needle tip forces it to 
assume a conformation that is compatible with the MxiH-IpaD interactions demonstrated 
here (5, 55, 61). High resolution structures are also available for the MxiH/IpaD 
counterparts in B. pseudomallei, BsaL/BipD, and a similar BsaL-BipD binding model can 
be generated in which the two-helix bundle of BsaL can be superimposed to the 
N-terminal helices of BipD, also with a Cα root mean square deviation of 3.2 Å (Dr. 
Roberto De Guzman, unpublished results). The NMR structure of PrgI shows that it is 
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structurally homologous to MxiH and BsaL (182). The homology of SipD with BipD and 
IpaD suggests similarities in the structure of SipD. This suggests that the model of 
MxiH-IpaD or BsaL-BipD interaction might indicate a common feature of needle tip 
interaction for Shigella, Salmonella, and Burkholderia TTSAs.  
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CHAPTER 5: NMR Analysis of the Influence Deoxycholate (DOC) Binding 




Invasion Plasmid Antigen D (IpaD) has long been known as one of three 
translocators for the Shigella TTSS, which are essential for forming translocon pores in 
host cell membranes. These translocator pores (translocons) are required for triggering 
uptake by host cells and for later effector protein injection into the host cytoplasm. 
Although IpaB and IpaC are the translocator proteins that possess hydrophobic regions 
and are actually inserted into the eukaryotic membrane, IpaB/IpaC translocon pore 
formation depends on IpaD. How IpaD carries out this function was not known until it 
was recently discovered that IpaD is localized at the tip of the needle prior to type III 
secretion induction (63). Discovery of IpaD’s position at the needle tip provided the first 
evidence that it serves as a conduit that connects the bacterial needle and the translocon 
pore embedded in the eukaryotic host membrane.  
IpaD is a dumbbell shaped protein with two globular domains flanking a central 
coiled-coil that stabilizes the protein (100). The N-terminal globular domain of this 37 
KDa protein consists of three ɑ-helices and it most likely resides near the needle tip 
following IpaD placement at the TTSA needle tip. A long C-terminal α-helix extends the 
entire length of the protein and packs against a second long α-helix in the middle of the 
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protein. The second long helix is required for interaction with MxiH which helps to 
anchor IpaD at the needle tip (190). The distal globular domain is made of a few short 
ɑ-helices and ß-strands that most likely point away from the needle tip (100, 137). 
Immunoelectron microscopy shows that only IpaD is presented at the needle tip prior to 
activation of the TTSS. The other two translocator proteins, IpaB and IpaC, are not seen 
at the needle tip at this early stage in TTSA biogenesis (63).  
It has been known for some time that growing Shigella in Tryptic Soy Broth (TSB) 
containing bile salts increases Shigella’s adherence to and invasion of cultured HeLa cells 
(148). As mentioned above, IpaD is the only Ipa protein found exposed at the tip of the 
TTSA needle when Shigella are grown to log phase in TSB, however, when the bacteria 
are incubated in the presence of the bile salt deoxycholate (DOC), IpaB is recruited to the 
needle tip. The recruited IpaB is stably co-localized with IpaD at the needle tip to form a 
ternary complex consisting of MxiH, IpaD, and IpaB (137). As mentioned above, IpaB 
and IpaC form a translocon pore embedded in the host membrane which serves as the 
portal through which later effectors are injected directly into host cell cytoplasm. Because 
IpaB is hydrophobic and is known to bind to host membrane components involved in the 
bacteria entry process, the stable presence of IpaB at the TTSA needle tip may be 
essential for preparing the bacteria sensing host cell (90, 114, 164). IpaB recruitment to 
the needle tip is not accompanied by induction of TTS as determined by analysis of 
Shigella culture supernatants. 
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IpaD present at the TTSA needle tip is proposed to function as a sensor of 
environmental signals to trigger the first step of type III secretion. IpaB is recruited to the 
Shigella surface where it stably co-localizes with IpaD within minutes following DOC 
addition to the medium (137). Bile salts are natural detergents within the human small 
intestine and they represent an attractive environmental trigger for inducing IpaB 
localization to the TTSA needle tip as Shigella passes through the human small intestine. 
This would suggest that IpaB is the TTSS protein that senses actual host cell contact, 
perhaps by interacting with host membrane components, to trigger IpaC secretion into 
host cytoplasmic membrane where it and IpaB form the translocon pore. Our hypothesis 
is that bile salts bind directly to IpaD and this interaction causes a conformational change 
in IpaD that leads to the recruitment of IpaB to the bacterial surface.  
IpaD is a stable and highly soluble protein that is convenient to work with in vitro. 
Fluorescence polarization (FP) experiments using unlabeled IpaD titrated into FITC-DOC 
were initially performed to demonstrate whether there is an interaction between DOC and 
IpaD (165). The polarization value of FITC-DOC increased upon the addition of IpaD, 
suggesting that they indeed interact. Molecular modeling suggested that DOC binds to the 
middle of the central coiled-coil of IpaD where the top of the N-terminus packs against 
the coiled-coil. NMR spectroscopy was also applied to examine this interaction by using 
unlabeled DOC titrated into 15N-labeled IpaD. Chemical shift perturbation of IpaD 1H-15N 
correlation indicates the binding of DOC to IpaD also influences the protein’s 
conformation. Backbone assignment of IpaD was made in order to identify the IpaD 
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residues potentially involved in this interaction. Identified IpaD residues that may be 
essential for DOC binding were chosen and mutated to potentially disturb DOC binding 
while not altering IpaD’s stable presence at the TTSA needle tip.   
 
Result 
Deoxycholate interacts with IpaD based on florescence polarization 
measurements. When S. flexneri is grown to early log phase in TSB, IpaD is already 
present at the tip of the TTSA needles. IpaB and IpaC are not presented on the bacterial 
surface under these conditions. When DOC is added in the medium, IpaB (but not IpaC) 
was observed on the bacterial surface within 15 min where it co-localized with IpaD at 
the tip of the TTSA needle (C. Epler, manuscript submitted). Thus, we hypotheze that 
DOC binds to IpaD, causing a conformational change in the protein that promotes the 
mobilization of IpaB to the Shigella surface and, more specifically, the co-localization of 
IpaB with IpaD at the TTSA needle tip. This is not accompanied by full induction of type 
III secretion and this may represent the first discrete step in type III secretion induction. 
To demonstrate that DOC’s effects on the TTSS are due to the direct interaction 
between IpaD and DOC, fluorescence polarization (FP) measurements were used to 
measure the interaction in vitro. FP spectroscopy measures the rotational diffusion of a 
fluorescent molecule in solution. Small molecules rotate faster than large molecules in 
solution, which results in smaller polarization value. In contrast, large molecules have a 
larger polarization value. The association of a small fluorescent molecule with a larger 
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nonfluorescent molecule will result in an increase in the overall volume size of the 
fluorescent complex, thus leading to an increased polarization value. In this case, adding 
unlabeled IpaD into fluorescein-labeled DOC should result in a significant polarization 
value change since IpaD is a much larger molecule than DOC, thus providing a confident 
measure of the interaction. DOC was labeled with amine-reactive 
fluorescein-4-isothiocyanate after adding a diaminohexyl tether to the carboxyl group of 
DOC. This new DOC derivative, called FITC-DOC, was synthesized by Dr. Ken Stensrud 
(Department of Chemistry, University of Kansas) specifically so that the IpaD-DOC 
interaction could be examined in vitro by FP analysis. FITC-DOC was added into 
Shigella TSB medium to determine whether attachment of the fluorophore affected the 
biological activity. The FITC-DOC was still able to stimulate the recruitment of IpaB to 
the Shigella surface (165).  
FP measurements were obtained using a Beacon fluorescence polarimeter (Panvera 
Corp.) with assistance from Dr. W. D. Picking and P. R. Adam (Department of Molecular 
Biosciences, University of Kansas). IpgC, the cytoplasmic chaperone for translocators 
IpaB and IpaC, served as the negative control in these experiments (Figure 12). A 
constant concentration of FITC-DOC (30 nM) in PBS was mixed with increasing 
concentrations of protein (μM range). The polarization value change of FITC-DOC was 
monitored as a change in millipolarization units (ΔmP) and plotted against protein 
concentration. The initial polarization value for FITC-deoxycholate was 27.5 mP, which 




Figure 12. Fluorescent polarization change of FITC-DOC incubated with 
nonfluorescent IpaD. 30 nM FITC-DOC was incubated separately with nonfluorescent 
IpaD (closed circles), SipD (open circles), BipD (closed triangles), and IpgC (open 
triangles). IpgC is a Shigella cytoplasmic chaperone and was used here as a negative 
control. The starting mP for FITC-deoxycholate is 27.5 (FP experiments were performed 
by P. R. Adams and Dr. W. D. Picking) (165). 
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added into FITC-DOC solution, different polarization value changes were observed. The 
maximum increase of polarization value of FITC-DOC was with IpaD, which was about 
250 mP units. When FITC-DOC was associated with SipD, the IpaD homolog from the 
enteric pathogen Salmonella typhimurium, there was also an increase of about 160 mP. In 
contrast, BipD, the IpaD homolog from the pulmonary pathogen Burkholderia 
pseudomallei did not seem to affect the polarization value of FITC-DOC, indicating that 
no interaction occurred with the purified BipD. These findings suggest that DOC interacts 
with IpaD to cause conformational changes in IpaD that may result in the recruitment of 
IpaB.  
Molecular modeling defines the DOC binding site on IpaD. The FP 
measurements demonstrated that there is a direct interaction between DOC and IpaD, 
however, they do not provide information on where DOC binds to IpaD or identify and 
the amino acids of IpaD that are involved in the binding. Computational analyses were 
used to dock DOC onto the crystal structure of IpaD to help predict whether DOC 
consistently binds to IpaD and whether there is a likely binding pocket for this 
interaction. Dr. G. H. Lushington (Department of Chemistry, University of Kansas) 
performed these computational simulation experiments and the results are shown in 
Figure 13. Briefly, IpaD structures were imported into SYBYL from their native PDB 
format (PDB number 1HGU) to make the simulations. One hundred docked complexes 
that show the lowest energy level for each DOC-IpaD pair were then generated. From the 
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computational molecular docking analyses, it appears that the putative DOC IpaD binding 




Figure 13. Computational simulated docking of deoxycholate onto the crystal 
structure of IpaD. α-helices of the ribbon structure of IpaD are shown in magenta, 
β-strands are shown in yellow and random coils were shown in light blue. A) DOC 
docked onto the ribbon structure of IpaD. B) Enlarged version of the binding pocket 
showing key residues of IpaD (L75, S82, E154, H155 and S158) that are essential for the 
interaction (165). Other residues that may contribute to the binding are also identified 
(computational simulation was done by Dr. G. H. Lushington). 
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is located on the central coiled-coil of the protein where the top of the N-terminal 
helix-turn-helix globular domain packs against the coiled-coil. Docking analyses using 
FITC-DOC as the ligand generated the same binding interaction, suggesting that it binds 
in the same way as unmodified DOC (data not shown). Within the IpaD coiled-coil, K151, 
E154, H155 and S158 appear to provide H-bonds as well as hydrophobic interactions and 
are essential for DOC binding (Figure 13). N-terminal globular domain residues L75 and 
S82 also seem to contribute to the interaction, however, additional docking simulations 
suggested that the IpaD N-terminal domain is not essential for the binding interaction 
because docking simulations using a truncated form of IpaD (IpaDΔ1–120) resulted in the 
same binding model involving the central coiled-coil. This finding is consistent with FP 
measurements using recombinant IpaDΔ1–120 that showed similar binding between 
FITC-DOC and IpaDΔ1–120 as seen with FITC-DOC and full-length IpaD (Dr. W. D. 
Picking, unpublished results). The identification of a putative DOC binding site on IpaD 
now provides the basis for further molecular analyses. 
Identification of IpaD residues interacting with deoxycholate by NMR 
Spectroscopy. Although computational simulations identify a putative binding pocket for 
the DOC-IpaD interaction, experimental information is still needed to determine whether 
this binding site is indeed real and to precisely identify the residues involved in the DOC 
binding event. NMR chemical shift mapping was used to identify the MxiHCΔ5 residues 
that are responsible for anchoring IpaD at TTSA needle tip (see Chapter 4) and a similar 
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approach seemed feasible here for the identification of IpaD residues responsible for 
DOC binding.  
a. NMR spectroscopy as a tool for identifying of protein residue involved in ligand 
interactions 
Nuclear magnetic resonance (NMR) spectroscopy is a powerful technique for 
identifying molecular interactions and to measure the dynamics of a protein. In a 1H-15N 
HSQC (Heteronuclear Single Quantum Coherence) NMR spectrum, the NMR signal of 
an amide nitrogen is connected with the proton attached to it. This correlation of the 
amide proton and nitrogen results in a two-dimensional NMR spectrum that produces a 
single peak for every amide group that represents each residue in the protein of interest. 
The peak’s position in the spectrum, which is defined by its 1H and 15N chemical shifts, 
provides information on the protein’s primary sequence and secondary structure. The 
chemical shift changes when the local chemical environment of each nucleus changes, 
thus giving information on the local chemical environment surrounding the nucleus, and 
therefore structural information. Each protein has its own characteristic 1H-15N HSQC 
spectrum because of its sequence and structure. NMR chemical shift is useful in studying 
molecular interactions involving proteins. When a protein interacts with a binding partner, 
the residues that are affected by the binding interaction will have a different chemical 
environment, which results in changes in the corresponding NMR signals of the specific 
residues affected by the interaction. If the sequence specific assignment of the protein of 
interest is available, the shifted peaks indicate which amino acids in the protein are 
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affected by the binding. The residues that show chemical shift changes are deemed 
potentially involved in the binding interaction. These perturbed residues can be mapped 
onto the three dimensional structure of the protein to visualize the binding site. 
 
b. Choice of NMR experiments for IpaD sequence assignment and chemical shift 
mapping 
In order to map the residues showing chemical shift perturbation onto the 
three-dimensional crystal structure of IpaD, the backbone sequence assignment of the 
protein needs to be known. Unfortunately, the specific sequence assignment of a protein 
cannot be made directly from HSQC spectra. A number of additional three-dimensional 
NMR spectra have to be collected and analyzed. The 37-kDa IpaD is a relatively large 
protein for NMR experiments. A major problem for large proteins in NMR is signal 
overlap due to overcrowding of peaks in the NMR spectra. Another problem is that large 
proteins show poor resolution in NMR signals because of broadened peaks. Deuteration 
can be used to improve the quality of NMR signals by reducing overlap proton signals. 
Deuteration also improves the resolution of experiments by eliminating many 
proton-proton dipolar and scalar couplings. To introduce deuterium, the bacteria 
expressing the protein are grown in D2O medium instead of H2O medium (163). More 
importantly, the development of TROSY (transverse relaxation-optimised spectroscopy) 
based experiments help to cope with large size proteins in NMR spectroscopy (143). 
TROSY makes use of the interference of two different relaxation mechanisms that affect 
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the signal broadening by selecting the optimal case when the two relaxation mechanisms 
cancel each other out. The resulting peak is sharp and narrow in a spectrum, which 
reduces the overlap problem for large proteins. IpaD assignments can thus be obtained by 
using 1H-15N TROSY correlation and TROSY-based 3-dimentional experiments. This is 
the basis for identifying IpaD residues that are potentially involved in the DOC-IpaD 
interaction and which thus make up the binding site. 
 
c. IpaD backbone sequence specific assignment  
     The initial HSQC spectrum of full length IpaD had broad peaks and major 
overlapping of peaks caused by the large size of the protein and its highly α-helical 
nature. In the crystal structure of IpaD, the first 37 residues and the last 11 residues of the 
protein were probably unstructured since there was no electron density detected for these 
in the IpaD crystal structure (100). A truncated version of IpaD based on the derivative 
used for determining the IpaD crystal structure was made in order to remove the 
unstructured ends to obtain better resolved NMR spectra. IpaD38-321 lacking the first 37 
and the last 11 amino acids of the protein was constructed with a C-terminal short His6tag 
and put into pET22b for production and easy purification. Uniformly 2H-, 15N-, 
13C-labeled proteins were obtained by growing the expression strain E. coli BL21(DE3) in 
minimal media made with D2O instead of H2O and supplemented with 15N-NH4Cl and 
2H-, 13C-glucose as the nitrogen and carbon sources, respectively. The deuterated sample 
was used for 3-D NMR data acquisition. Although protein production was reduced in the 
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D2O medium compared with the H2O medium, 500 ml of bacterial culture produced 
enough triple labeled IpaD38-321 for NMR data collection (Figure 14).  
Uniformly 2H-, 15N-, 13C-labeled truncated IpaD was dissolved in NMR buffer for 
data collection. The data were acquired at 30 °C on a Bruker Avance 800 MHz 
spectrometer, processed using NMRPipe and analyzed using NMRView (56, 99). 
Backbone resonances of truncated IpaD were assigned using 1H-15N TROSY, 
TROSY-based 3-D HNCA and HNCACB (143).  
15N specific amino acid labeling was also used to obtain IpaD in which only a single 
type of amino acid in the protein was 15N labeled. In this case, a single specific 
15N-labeled amino acid was added to minimal medium containing the other 19 unlabeled 
amino acids. The 15N-amino acid labeled protein could be expressed and purified 
normally. On a 1H-15N TROSY spectrum only the labeled specific amino acids would 
show up but no others. IpaD labeled with 15N-Alanine, 15N-Valine, 15N-Leucine, 
15N-Isoleucine, 15N-Phenylalanine and 15N-Tyrosine were produced separately and the 
1H-15N TROSY spectrum for each of the single amino acid labeled IpaD38-321 was 
collected for aiding in making backbone assignments (Figure 15).  
The highly α-helical nature of IpaD, especially as part of an intramolecular 
coiled-coil, made sequence assignment challenging since NMR signals tend to appear in a 
very narrow proton range. Thus, peak overlapping, which is packed into a small region of 
the NMR spectrum, had to be resolved. In spite of this hurdle, the multiple NMR 




Figure 14. SDS-PAGE of isotopically labeled IpaD38-321. Top: 15N-labeled IpaD38-321 
expressed and purified from 500 ml H2O minimal medium; Bottom: 2H-, 15N-, 13C-labeled 
IpaD38-321 expressed and purified from 500 ml D2O minimal medium. 15 μl of protein 
sample from each 1.5ml fraction collected after nickel chelation affinity chromatography 
was loaded onto the 12% SDS-PAGE gel, and total of 10 fractions were collected while 




Figure 15. Overlay of the TROSY spectra of IpaD38-321 containing specifically labeled 
amino acids. TROSY spectra of different labeled IpaD samples were collected at 30 °C 
on a Bruker Avance 800 MHz spectrometer (black, Leu; red, Val; blue, Phe; green, Tyr; 
yellow, Ile; magenta, Ala).  
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(Figure 16). The backbone sequence assignment of IpaD now provides the basis for 
interpreting chemical shift mapping data for identifying the IpaD residues involved in 
DOC binding.  
 
d. Chemical shift mapping to identify the DOC binding site on IpaD 
Based on the reasoning that the DOC-IpaD interaction should result in changes in the 
NMR resonances of the IpaD for amino acids whose chemical environments are changed 
by contact with the ligand, DOC was titrated into 15N-labeled IpaD38-321. The changes in 
the chemical shifts of IpaD were thus determined. Indeed, there are peaks in the IpaD 
1H-15N TROSY spectrum that are perturbed upon the addition of DOC (Figure 17). The 
observation of chemical shift perturbations for IpaD when DOC is added confirms that 
DOC binds to IpaD and this is consistent with the FP data presented earlier. Interestingly, 
the characteristic chemical shift of the Trp side chain signal (bottom left corner of the 
spectrum) was perturbed, indicating that one of the four Trp residues in IpaD is 
potentially involved in DOC binding. It was later determined that the perturbed Trp side 
chain belongs to Trp177 using mutagenesis in combination with NMR spectroscopy (data 
not shown). Because there are no Trp residues within the expected DOC binding pocket, 
perturbation of the Trp177 chemical shift indicates that DOC binding could be inducing 
conformation changes in IpaD. 
Several 15N TROSY spectra with increasing amounts of DOC added to 15N-labeled 




Figure 16. TROSY spectrum of IpaD38-321 with its primary sequence assignment. 
Sequence assignment was made by collecting 1H-15N TROSY, TROSY-based 
3-dimensional HNCA and HNCACB from uniformly 2H-, 15N-, 13C-labeled IpaD38-321. 
The data were acquired at 30 °C on a Bruker Avance 800 MHz spectrometer, processed 
using NMRPipe and analyzed using NMRView. Specific amino acid labeling (see Figure 




Figure 17. Chemical shift perturbation of 15N-labeled IpaD38-321 caused by adding 
DOC. The TROSY spectrum of free 15N-labeled IpaD38-321 (black) was overlaid with 
15N-labeled IpaD38-321 bound to equal molar ratio of DOC (red). The chemical shifts of 
some IpaD residues were perturbed upon the binding of DOC, and some of the key 
residues are pointed with black arrows. 
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labeled IpaD, many IpaD peaks shifted. Further additions of DOC moved the peaks from 
their original positions even further, indicating that this binding interaction was in the fast 
exchange NMR time scale (Figure 18). This behavior is consistent with the micromolar 
binding affinity estimated from the FP experiments (Figure 12 and Figure 18).  
Since the majority of the IpaD residues have been assigned based on the TROSY 
spectrum, most of the residues showing chemical shift perturbation can be identified. 
Those perturbed residues are listed in Table 6 and mapped onto the crystal structure of 
IpaD in Figure 19. The identified residues of IpaD for DOC-IpaD interaction from NMR 
chemical shift mapping are consistent with computational models of DOC docking. 
Several residues within the putative binding pocket identified via molecular modeling 
showed chemical shift changes upon the titration of DOC (see Figure 13). Key residues 
that are supposed to be involved in the binding interaction based on computational 
analyses, including S82 and S86 in the N-terminal globular domain and H155 and S158 
in α-3 of the coiled-coil, showed chemical shift perturbations in these NMR experiments. 
K72, which is at the upper end of the binding pocket, also had a chemical shift change. 
Residues L150, Y153 and T161 are all in the predicted binding pocket and they showed 
chemical shift perturbations although they were not specifically pointed out in Figure 13. 
Interestingly, many IpaD residues in α-3 of the coiled-coil showed chemical shift 
perturbations although being higher on α-3 than E147. The perturbed α-3 residues 
extended all the way up to the distal domain along the helix. The short linker connecting 




Figure 18. Titration of 15N-labeled IpaD38-321 with increasing amounts of DOC. 
Overlay of four protein-nitrogen correlation spectra (15N TROSY) at various DOC:IpaD 
molar ratios (black, 0; red, 1.0; green, 3.0; magenta, 6.0). The actual DOC:IpaD 
concentrations used, repectively, are as follows (in µM): black (500:0), red (500:500), 
green (500:1500), and magenta (500:3000).  
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Table 6. IpaD residues identified as showing chemical shift perturbations 
upon titrating in DOC 
 
N-terminal domain  T69, L70, T71, K72, S82, S86 
α-3 of the coiled-coil Q148, Y149, L150, Y153, H155, S158, 
T161, F167, V170, S172, S173 
Linker between α-3 and the distal domain  G176, W177, I178 
Distal domain K189, L190, A198, E201, K205, Y206, 
Y212, N216, A223, N224, G232, T233, 
I234, K236, S238, V245, V246, M250 





Figure 19. IpaD residues that are perturbed by DOC binding are mapped on the 
surface of the crystal structure of IpaD (Protein Data Bank code 2j0o). The ribbon 
structure of IpaD is shown in green, and the perturbed residues (listed in Table 6) are 
highlighted in red. Two pictures show opposite faces of the IpaD structure.   
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I178 are also perturbed upon DOC binding. The side chain signal of W177 showed 
significant chemical shift perturbation at the bottom left corner of the TROSY spectrum. 
Residues throughout the distal domain also had chemical shift changes, suggesting that 
DOC binding induces a global conformational change in the protein, which may be 
involved in the transient secretion induction (IpaB mobilization) and possibly the stable 
maintenance of IpaB at the TTSS needle tip following the addition of DOC to whole 
bacteria.  
Mutagenesis studies of the IpaD residues that are suggested to interact with 
DOC by NMR spectroscopy. There are some residues in the IpaD N-terminal domain 
that are perturbed upon DOC binding, however, the N-terminal domain most likely does 
not reside next to the coiled-coil in vivo due to the steric hindrance expected to occur 
when IpaD is present at the needle tip. Thus, site-directed mutations were focused on the 
residues of the central coiled-coil which are proposed to be directly involved in DOC 
binding. Changes at S158 and K151 in the central coiled-coil had the most dramatic effect 
on IpaD-dependent invasion of cultured cells (Table 7). S158A resulted in an nearly 80% 
decrease in invasiveness and S158L (predicted to abolish DOC binding according to 
computer simulations) completely eliminated Shigella invasiveness. Experiments to more 
fully characterize these mutants are under way, however, S158A is also impaired in its 
ability to mobilize IpaB to the Shigella surface following DOC addition. In contrast, 
K151E resulted in a dramatic increase in Shigella invasiveness while being largely 
normal with respect to IpaD and IpaB presentation on the bacterial surface.  
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Table 7. The effect of selected IpaD mutations on Shigella invasiveness. 
   
                    IpaD exposedb   IpaB exposedc 
IpaD mutant  Relative invasiona   -DOC   +DOC   -DOC   +DOC 
ipaD null strain (SF622) 0±0 0% 0% 0% 0% 
Wildtype 100±8 100 100 0 95 
S158A 22±4 95 94 0 30 
S158L 0±0 nd nd nd nd 
N146Q 21±3 nd nd nd nd 
Y149F 23±8 nd nd nd nd 
N146Q/Y149F 4±3 nd nd nd nd 
K151E 421±21 100 100 0 100 
E229K 58±9 80 77 0 22  
K151E/E229K 0±0 28 13 0 18  
 
Mutants made for this study are highlighted in bold and the number of bacteria having 
specific proteins on their surface was determined by immuno-fluorescence microscopy 
with help from C. Epler. 
a) Invasion was measured using a standard gentamycin protection assay with the S. 
flexneri ipaD null strain SF622 serving as a negative control and SF622 making wild-type 
IpaD having 74±6 colonies per well (n=3).   
 b) IpaD staining was with monoclonal antibodies and cIpaB staining was with rabbit 
antisera. In both cases the value given is the percentage (%) of cells having the given 
protein on their surface.  
nd = not yet determined. 
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Based on information revealed in solving the original crystal structure, there is a 
region consisting of four residues in the middle of helix α3 within the central coiled-coil 
of IpaD that develops a kink which could contribute to conformational changes that occur 
within the protein following ligand binding. Therefore, additional mutants were generated 
to stabilize the helical conformation within this region of α-3 to limit conformational 
change of IpaD, which may affect the recruitment of IpaB. The mutants N146Q, Y149F 
and N146Q/Y149F (Table 7) were generated to further stablilize the α-helix. In doing 
this, we expected that a reduction of flexibility in this region might affect the overall 
conformational change of IpaD. If such a structural change is important for 
IpaD-mediated virulence functions, these mutants should be noninvasive while retaining 
IpaD at the Shigella surface. N146Q and Y149F indeed have decreased Shigella 
invasiveness while the N146Q/Y149F double mutant almost abolishes the invasiveness 
(Table 7). These data suggest that helix α-3 does play a key role in signaling the first step 
in TTS induction. However, additional experiments, including NMR experiments, will 
need to be completed to fully understand the affect of the mutations. Meanwhile, 
examination of IpaD’s presence on Shigella surface of these mutant strains and IpaB 
recruitment to the Shigella surface are ongoing.  
 
Discussion 
Fluorescence polarization (FP) measurements were initially used to show that FITC-DOC 
directly interacts with IpaD. Dr. G. Lushington (Director, KU Molecular Graphics and 
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Modeling Lab) then performed docking simulations to provide details on the putative 
IpaD binding pocket for DOC (see Figure 13). Molecular modeling predicted that DOC 
binds to a portion of the central coiled-coil where it associates with the turn of the 
N-terminal double helix. A truncated form of IpaD lacking its N-terminal domain 
(IpaDΔ1-120) gave similar binding results.  
A new construct encoding IpaD38-321 (291 residues with His-tag) designed based on 
the IpaD form used to solve its crystal structure was used for the NMR studies. Over two 
thirds of the IpaD residues have been assigned using TROSY-based 3-D data collected on 
2H, 15N, 13C-labeled IpaD38-321. In addition to the work presented, these IpaD assignments 
provide the basis for further studies on the structural dynamics of IpaD in the presence of 
other ligands or unlabeled proteins. We have identified a number of IpaD residues that are 
perturbed when titrated with unlabeled DOC (Figure 18 and Table 6). The perturbed 
residues are mapped onto the crystal structure of IpaD, which shows a pattern that is 
consistent with computer docking analyses. IpaD residues in the predicted DOC binding 
pocket, including Y149, H155, S158 and T161, are all perturbed upon DOC binding 
(Figure 19). While K151 has not yet been assigned, the residues perturbed by DOC 
binding flank this important amino acid. Furthermore, those residues altered by DOC 
binding extend from the DOC binding pocket and continue up α-3 (including F167, V170, 
G176 and W177) and eventually lead into the distal domain (Figure 19). Residues whose 
chemical enviroments are perturbed within the distal domain are presumably affected due 
to conformational changes in IpaD. From these studies, we show that NMR is providing a 
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precise map of the residues involved in DOC binding and strengthening arguments for 
exploring the role of the IpaD distal domain in IpaB recruitment and anchoring at the 
Shigella TTSA needle tip.   
A potential conformational change was predicted by molecular modeling in the loop 
between α-1 and α-2 (Q67-K72) of the N-terminal domain following simulated DOC 
binding coupled with protein relaxation (see Figure 13)(Dr. G. Lushington). Because of 
our proposal that the IpaD N-terminus (α-1 and α-2) is replaced by the head domain of 
MxiH at the needle tip when IpaD is docked at the needle tip, we have not focused on this 
portion of the protein in this study (190). Nevertheless, the possibility that DOC binding 
may alter the IpaD-MxiH interface is intriguing from the stand point of how DOC may 
elicit signals that influence TTS events occurring within the TTSA. 
Residues N146 to Y149 of helix α3 within the central coiled-coil of IpaD appear to 
develop a kink that may contribute to additional conformational changes within the 
protein. Therefore, the mutants in this study were mainly generated to alter DOC binding 
or stabilize the helical structure within this region of α-3. In doing this, we expected that 
the predicted DOC-induced IpaD conformational change would be compromised. N146Q 
and Y149F do partially decrease the Shigella invasiveness, while the N146Q/Y149F 
double mutant greatly reduces the invasiveness (Table 7), however, further investigation 
of IpaD’s behavior on the bacterial surface and IpaB’s recruitment to the Shigella surface 
is still needed for these mutants. Helix α-3 may play a key role in signaling for the first 
step in TTS induction and in accommodating the recruitment and maintence of IpaB at 
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the TTSA needle tip. 
Based on our dynamics simulations and experimental results, we propose that IpaD 
undergoes a conformational change that allows IpaB to be recruited at the needle tip in a 
controlled manner. There are specific residues in IpaD that either interact with DOC 
directly or may be involved in conformational changes following DOC binding. Thus, our 
working hypothesis is that DOC induces this conformational change in IpaD to allow the 
controlled release of IpaB to give rise to a MxiH-IpaD-IpaB ternary complex.  
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CHAPTER 6: Discussion and Summary  
 
Type ІІІ secretion is a tightly regulated process that is common among many 
Gram-negative pathogens. The TTSA is a complicated, protein-exporting nanomachine 
used to deliver bacterial effectors directly into a target eukaryotic host cell’s membrane 
and cytosol. Phylogenetic analysis suggests that various TTSSs can be organized into five 
groups (75, 139, 177). The Ysc group includes the Yersinia Ysc TTSS, the P. aeruginosa 
Psc TTSS, and the Bordetella Bsc TTSS. The Hrp group includes P. syringae and 
Erwinia TTSSs. The Hrp2 group includes Xanthomonas and Ralstonia TTSSs and one of 
the two Burkholderia TTSSs. The Inv/Mxi/Spa group includes the Samonella SPI-1 
TTSS, the Shigella TTSS and the Burkholderia Bsa TTSS. The Esa/Ssa group includes 
the TTSS of EPEC and the Salmonella SPI-2 TTSS. Among the 25 or so species of 
Gram-negative bacteria now known to possess a TTSS, there are more than 100 different 
effector proteins having a wide range of activities that interfere with the normal function 
of host regulatory proteins (41). Effector proteins from different bacteria can be very 
different in terms of structure and function, however, the TTSA is relatively 
well-conserved structurally and functionally (16, 53, 110, 112, 128, 134, 162, 171).  
The TTSA is composed of about 25 different types of proteins, most of which are 
located adjacent to the bacterial inner membrane. First visualized by transmission electron 
microscopy (TEM) by Kubori et al. in S. typhimurium, the TTSA is a multifunctional 
protein complex that visually resembles a syringe and needle (112). Most of the TTSA 
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structural components are associated with the bacterial inner membrane which anchors 
the complex and provides the energy needed for translocation of later structural units, 
translocator proteins and effectors (160).  
The major component of the extracellular portion of the TTSA is a needle assembled 
from multiple copies of a single protein. It is believed that needle monomers pass through 
the channel and polymerize at the growing distal end of the needle. Studies have shown 
that the needle proteins are critical for TTSS function and the null mutants are defective 
in secreting any virulence effectors (107). Needle proteins from a wide range of 
organisms share sequence similarities at key positions. Due to the efficient 
self-polymerizing nature of these proteins, structure determination was challenging, 
however, structures are now becoming available for a number of different needle 
monomers (55, 182, 191). Although different approaches have been used to obtain 
high-resolution structures for BsaL (B. pseudomallei) (191), MxiH (S. flexneri) (55), PrgI 
(S. typhimurium) (182), PscF (P. aeruginosa) (151) and YscF (Y. pestis) (169), common 
themes in the core needle monomer structure are apparent. 
The NMR structure of BsaL was the first protein structure within the needle protein 
monomer class to be reported (191). BsaL is a helix-turn-helix with a tight PSDP turn. 
The N-terminal and C-terminal ends adopt partial helical features that flank a 
well-defined two helix bundle core. The two helix bundle is stabilized by hydrophobic 
interactions and the surface of the core domain is lined with polar residues that might be 




Figure 20. Structures of TTSS needle and tip proteins. Ribbon structures are shown 
for the needle protein monomers BsaL (PDB ID: 2g0u) from B. pseudomallei (A), MxiH 
(PDB ID: 2ca5) from S. flexneri (B), PrgI (PDB ID: 2jow) from S. typhimurium (C), PscF 
(PDB ID: 2uwj) from P. aeruginosa (D) and YscF (PDB ID: 2p58) from Y. pestis (E). 
Also shown are the structures of the needle tip proteins LcrV (PDB ID: 1r6f) from Y. 
pestis (F), BipD (PDB ID: 2j9t) from B. pseudomallei (G) and IpaD (PDB ID: 2j0o) from 
S. flexneri (H) (55, 57, 100, 151, 169, 182, 191).  
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shows a similar conformation, but it has a longer C-terminal helix (Figure 20B) (55). The 
NMR structure of PrgI revealed a two helix bundle with flexible ends similar to the 
structures of BsaL and MxiH, however, the electrostatic surfaces of PrgI appear to differ 
from those of BsaL or MxiH (Figure 20C) (182). The latter finding suggests that 
electrostatic interactions are important contributing factors in needle assembly. The 
purified needle proteins of P. aeruginosa and Y. pestis behave differently from BsaL, 
MixH and PrgI (151, 169). Deleting a small number of C-terminal residues does not lead 
to readily purified monomers for these proteins. The partial structure of P. aeruginosa 
PscF was only solved crystallographically when it was bound to its chaperones PscE and 
PscG (151). In this ternary complex, the first 54 residues of PscF were deleted to generate 
a crystal that was diffractable with high resolution (Figure 20D). The C-terminal 31 
residues of PscF in the complex form an extended coil and a short helix that is similar 
with the C-terminal helix of MxiH. The PscE/F/G ternary complex may provide an 
indication as to how bacteria can prevent needle monomers from prematurely 
self-polymerizing in the bacterial cytoplasm, however, no chaperones have been reported 
for BsaL, MxiH, or PrgI.  
The crystal structure of Y. pestis needle protein YscF in complex with its chaperones 
YscE and YscG was recently published by Sun. et al (169). It is worth noting that 
although the first 49 residues of YscF displayed no electron density within its ternary 
complex, residue 50-87 did adopt a helix-turn-helix structure (Figure 20E). The two 
helices of YscF are joined by a five-residue linker from I64 to N68, which differs from 
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the previous reported needle monomer structures which all have a short four-residue 
Pro-X-X-Pro turn. 
The atomic structures of needle proteins have provided a basis for explaining 
biological data related to the phenotypes of needle protein mutants, however, empirical 
data on how needle monomers interact with each other for needle assembly and how 
relatively large proteins are able to traverse these needles are still lacking (107, 169). 
Furthermore, how or even whether this portion of the TTSA is structurally altered during 
the process of protein secretion is still unclear. Nonuniformity in needle length, both for 
isolated needles and needles reconstituted in vitro, make crystallization of assembled 
needles unlikely.  
Available models of needle assembly have been generated by docking the crystal 
structure of the MxiH monomer into a 16 Å cryo-EM electron density map of the S. 
flexneri needle (55). Since the N terminus of the MxiH monomer is not visible in the 
published crystal structure, a helical structure for this part of the molecule was assumed 
for this model. The major axis of the monomer was in line with the major axis of the 
needle (Figure 21). The orientation of this model is in agreement with the functionally- 
and structurally-related bacterial flagellar filament assembly (55, 155, 186). The 
monomer tails were buried inside the needle wall in this model with the head domain 
localized at the outside surface. The N-terminal helix is proposed to line the inner surface 
of the tunnel. The C-terminus of the monomer, which is buried within the needle wall, 




Figure 21. Molecular model of the Shigella TTSS needle assembly. Molecular 
modeling based on the crystal structure of MxiH (55) and cryo-EM pictures (38) has 
allowed for in silico reconstruction of the Shigella TTSA needle. A side view of the 
needle is shown on the left with an end-on view shown on the right (PDB file generated 
by Dr. W. Im, University of Kansas, based on MxiH structure (PDB ID: 2ca5)). 
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of MxiH has direct contact with three other molecules in the assembly. Deleting the five 
C-terminal residues of MxiH interferes with the self-polymerization and leads to 
monomeric MxiH. Published mutagenesis results agree with this model (107). 
It was not until late 2005 that a tip complex formed by LcrV of Yersinia was 
reported to exist at the top of the TTSA needle when the apparatus was in a resting state 
(129). This was quickly corroborated with the finding that IpaD forms a “tip complex” for 
the TTSA of S. flexneri (63). It is likely that these needle tip complexes are needed to 
sense environment signals and subsequently control the secretion and insertion of 
translocators into host membranes as the first step in translocon pore formation. Some of 
the known tip complex proteins have been sorted into specific classes based on sharing 
sequence similarity, especially within their C-terminal sequences. The X-ray structure of 
LcrV was the first reported in the LcrV/PcrV family (Figure 20F). LcrV has a dumbbell 
shape with a novel intramolecular coiled-coil motif formed by a long central helix and a 
C-terminal helix. This coiled-coil stabilizes the overall structure of the protein. Smaller α 
helices and β strands form the distal domain which, together with the N-terminal domain, 
flank the coiled-coil handle as the globular portions of the dumbbell. This coiled-coil 
motif was found to be a hallmark of TTSA tip proteins when the X-ray structures of BipD 
and IpaD revealed similar overall dumbbell shapes (Figure 20G and 20H). These proteins, 
however, possessed larger N-terminal globular domains. It is perhaps not surprising that 
the N-terminal domains of BipD and IpaD resemble the structure of the LcrV chaperone 
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LcrG since homologs of this chaperone are absent in Shigella and Burkholderia and it has 
been suggested that IpaD and BipD may possess a self-chaperoning ability. 
The presumed positioning of TTSA needle tip proteins suggests that they directly 
interact with the needle and the translocon pore. Precisely how tip complex proteins 
interact with the underlying needle monomers is currently unknown, however, different 
approaches have been made to try to address this question. The N-terminal 
helix-turn-helix domain of the Shigella tip protein IpaD looks remarkably like the 
two-helix bundle of the needle protein MxiH, suggesting a possible model for of needle 
monomer-tip protein interaction (190). We proposed that when IpaD is secreted and 
localized to the tip of the needle, its N-terminal domain swings away, leaving the binding 
interface of the coiled-coil motif accessible to MxiH. MxiH thus mimics the IpaD 
N-terminus and binds to the lower part of the coiled-coil motif in the same fashion as the 
N-terminus itself was previously bound to the coiled-coil motif (see Figure 11). NMR 
spectroscopy chemical shift mapping results and the findings from subsequent 
mutagenesis studies support the suggested binding interface. It has been shown that the 
N-terminal domain of IpaD is not buried inside needle and is exposed to outside 
environment where anti-IpaD antibodies can neutralize some IpaD functions (146), which 
is consistent with this model of needle tip complex assembly. Furthermore, only a small 
number of residues deleted from the C-terminus of IpaD are capable of leading to a 
dramatic decrease in of pathogen’s ability to infect cultured cells or to maintain IpaD at 
the needle tip (146). From the proposed model of IpaD retention at the MxiH needle tip, it 
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appears that the C-termini of needle tip complex proteins play an important role in 
stabilizing their interaction with the tip of the TTSA needle. It remains to be determined if 
this is also the case for other needle tip complex proteins and their respective needle 
partners. Because BipD is able to stably associate with the MxiH needle of S. flexneri and 
the C-terminal sequences of IpaD and BipD are quite conserved, this model seems 
plausible (100). Likewise, the divergence of C-terminal sequences for the LcrV/PcrV 
family and their inability to be retained at the Shigella MxiH needle tip are also consistent 
with this model. 
In general, the three translocators from different TTSSs share a common feature that 
two of them are hydrophobic (e.g. IpaB and IpaC in Shigella) and the third is hydrophilic 
(e.g. IpaD in Shigella) (16, 85). All three of them are encoded in a single operon, with a 
smaller chaperone protein serving for the hydrophobic translocators. The two 
hydrophobic translocators form a translocon pore in the host membrane where they create 
a path for later bacterial effectors to be delivered directly into the host cytoplasm (85, 97, 
183). The tip complex serves as a platform that connects the bacterial and host cell 
cytoplasms. The position of the tip complex suggests an interaction between tip proteins 
and translocators. Despite the high resolution structures of tip proteins, however, detailed 
structural information on the translocators is absent due to their overall hydrophobic 
nature. How the tip and translocon proteins interact with each other has not yet been 
worked out (137, 179). The bile salt DOC interacts with IpaD to recruit IpaB to the TTSA 
needle tip where it remains stably bound without further induction of TTS. NMR 
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chemical shift perturbation shows that there are specific residues in IpaD that either 
interact with DOC directly or are involved in conformational changes following DOC 
binding. Our hypothesis is that DOC induces a conformational change in IpaD, which 
allows IpaB’s secretion and its co-localization with IpaD at the TTSA needle tip to form a 
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APPENDIX A: Buffers and Reagents 
 
Agarose gel for DNA electrophoresis: 
 25ml 1X TAE 
 13ul 6mM Ethidium bromide 
 0.3g high melting DNA grade agarose 
 
Running buffer for agarose DNA gel (TAE): 
      4.84g Tris 
      1.142ml Acetic acid 
      2ml 0.5M EDTA 
      Dilute to 1000 ml 
 
HISBIND binding buffer:   
        5 mM imidazole 
        0.5M NaCl 
        20mM Tris-HCl pH 7.9 
       Adjust to pH 7.9 
 
HISBIND charge buffer:   
        50mM NiSO4 
 
HISBIND elute buffer:   
        1M imidazole 
        0.5M NaCl 
        20mM Tris-HCl pH 7.9 
       Adjust to pH 7.9 
 
HISBIND strip buffer:  
        100mM EDTA 
        0.5M NaCl 
        20mM Tris-HCl pH 7.9 
       Adjust to pH 7.9 
 
HISBIND wash buffer:   
        60mM imidazole  
        0.5M NaCl 
  20mM Tris-HCl pH 7.9 




 10g Tryptone 
 5g Yeast extract 
 10g NaCl 
 Dilute to 1000ml 
 
Luria-Burtani Agar: 
 10g Tryptone 
 5g Yeast extract 
 10g NaCl 
 15g agar   
Dilute to 1000ml 
 
M9 Minimal Media: 
 6.7g Na2HPO4 
 3.0g KH2PO4 
 1.5g NaCl 
  2ml 0.1M CaCl2 
  1ml 1M MgSO4 
  1g NH4Cl 
  10ml 40% glucose 
  10ml vitamin solution 
  1ml 1000× trace metal solution 
  Dilute to 1000ml 
 
Minimum Essential Medium Eagle (Modified) (MEME): 
 9.53g MEME 
 2.2g NaHCO3 
 Dilute to 1000ml and filter sterilize 
 
Minimum Essential Eagle (Modified) MEME + Calf Serum (CS): 
 9.53g MEME 
 2.2g NaHCO3 
 100ml calf serum 
 Dilute to 1000ml and filter sterilize 
 
Minimum Essential Eagle MEME + Gentamycin (GENT): 
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 9.53g MEME 
 2.2g NaHCO3 
 50ml calf serum 
 50mg gentamycin 
       Dilute to 1000ml and filter sterilize 
 
Minimum Essential Eagle MEME + Glucose (GLUC): 
 9.53g MEME 
 2.2g NaHCO3 
 4.5g glucose 
 Dilute to 1000ml and filter sterilize 
 
Phosphate-Buffered Saline (150mM PBS): 
 10mM Na2HPO4  
 1.5mM K2HPO4  
 130mM NaCl  
 3mM KCl  
  
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis  
(SDS-PAGE) destain:   
        5% (v/v) methanol 
        7.5% (v/v) glacial acetic acid 
 
SDS-PAGE running buffer:  
       2.42g Tris  
       14.41g glycine 
       1.0g SDS 
       bring to 1 liter with H20 
 
10% SDS-PAGE resolving gel:   
   3.33ml 29:1% (w/v) acrylamide:bisacrylamide 
        2.5ml 1.5 M Tris-HCl pH 8.8 
        0.1ml 10% (w/v) SDS 
       0.15ml 10% (w/v) ammonium persulfate (APS) 
13μl N,N,N’,N’-tetra-methylethylenediamine (TEMED) 
 
5% SDS-PAGE stacking gel:   
 2ml 29:1% (w/v) acrylamide:bisacrylamide 
2.5ml 0.5 M Tris-HCl pH 6.8 
0.1ml 10% (w/v) SDS 
88μl 10% (w/v) APS 
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        10μl TEMED 
         
SDS-PAGE stain:  
0.1% (w/v) Coomassie Brilliant Blue R-250 
        5% (v/v) methanol 
        7.5% (v/v) glacial acetic acid 
   
SOC Medium: 
2.0% tryptone 
   0.5% yeast extract 
   10mM NaCl 
   2.5mM KCl 
   10mM MgCl2-6H2O 
   20mM glucose 
   
Solution A: 
   0.8% (w/v) NaCl 
   0.04% (w/v) KCl 
   0.035% (w/v) NaHCO3 
   0.1% (w/v) glucose 
 
Trace Metal Solution 1000×: 
   5000mg FeSO4 







Dilute to 100ml 
 
Tryptic Soy Agar: 
   15g Tryptone 
   5g Soytone 
   5g NaCl 
   15g Agar 
   Dilute to 1000ml 
   
Tryptic Soy Broth: 
   15g Tryptone 
   5g Soytone 
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   5g NaCl 
   Dilute to 1000ml 
 
Tris-Buffered Saline (TBS): 
   2.42g tris base (20mM) 
   8g NaCl (137mM) 
   3.8ml 1M HCl 
   Dilute to 1000 ml and pH to 7.0 
 
Tris-Buffered Saline + 0.1% Tween 20 (TBST): 
   2.42g tris base (20mM) 
   8g NaCl (137mM) 
   3.8ml 1M HCl 
4ml 25% Tween 20 
Dilute to 1000 ml and pH to 7.0 
 
Uranyl acetate 2% 
   Diluted in distilled water at 2% w/v and filtered. 
   pH not adjusted 
























APPENDIX B: Table of Primers 
 
  











 MxiH21F GAGAGAGAGCAATTGCTGGCTGAATACCAAA 
MxiHN43K MxiH221R GAGAGAGAGCAATTGTGGTTTCGAAGGATTT
TTAGCTAATTT 




































































APPENDIX C: List of abbreviations 
 
CR – Congo red 
HSQC - Heteronuclear single quantum coherence 
Ipa – Invasion plasmid antigen 
Ipg – Invasion plasmid gene 
IPTG – isopropyl thio-β-D-galactoside 
kb – kilobase 
kDa – kilodaltons 
LB – Luria Bertani broth 
min – minute 
MW – molecular weigth 
Mxi – membrane expression of invasion plasmid antigen 
nm – nanometers 
NMR – nuclear magnetic resonance  
PBS – phosphate-buffered saline 
PCR – polymerase chain reaction 
SDS-PAGE – sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
Spa – surface presentation of invasion plasmid antigen 
spp. – species 
TTSS – type III secretion system 
TTSA – type III secretion appratus 
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TTS – type III secretion 
TBS – tris-buffered saline 
TSA – tryptic soy agar 
TSB – tryptic soy broth 
TROSY - Transverse relaxation optimized spectroscopy 
 
 
 
